| ENSG00000197332.7 |
Motesanib |
Breast invasive carcinoma |
0.021281434 |
Resistant |
| ENSG00000204934.6 |
Motesanib |
Breast invasive carcinoma |
0.013111811 |
Resistant |
| ENSG00000205037.2 |
Motesanib |
Breast invasive carcinoma |
0.029237877 |
Resistant |
| ENSG00000215458.4 |
Motesanib |
Breast invasive carcinoma |
0.046418236 |
Resistant |
| ENSG00000225146.1 |
Motesanib |
Breast invasive carcinoma |
0.045509303 |
Resistant |
| ENSG00000225493.1 |
Motesanib |
Breast invasive carcinoma |
0.038379543 |
Resistant |
| ENSG00000226688.2 |
Motesanib |
Breast invasive carcinoma |
0.003660764 |
Resistant |
| ENSG00000227704.1 |
Motesanib |
Breast invasive carcinoma |
0.022892925 |
Resistant |
| ENSG00000229124.2 |
Motesanib |
Breast invasive carcinoma |
0.032477563 |
Resistant |
| ENSG00000230054.1 |
Motesanib |
Breast invasive carcinoma |
0.030064859 |
Resistant |
| ENSG00000230606.6 |
Motesanib |
Breast invasive carcinoma |
0.015563453 |
Resistant |
| ENSG00000232019.1 |
Motesanib |
Breast invasive carcinoma |
0.003650028 |
Resistant |
| ENSG00000232063.1 |
Motesanib |
Breast invasive carcinoma |
0.042295612 |
Resistant |
| ENSG00000232640.1 |
Motesanib |
Breast invasive carcinoma |
0.022738823 |
Resistant |
| ENSG00000234753.1 |
Motesanib |
Breast invasive carcinoma |
0.046632696 |
Resistant |
| ENSG00000234773.2 |
Motesanib |
Breast invasive carcinoma |
0.031526286 |
Resistant |
| ENSG00000234789.1 |
Motesanib |
Breast invasive carcinoma |
0.029628972 |
Resistant |
| ENSG00000234793.1 |
Motesanib |
Breast invasive carcinoma |
0.043803534 |
Resistant |
| ENSG00000235423.4 |
Motesanib |
Breast invasive carcinoma |
0.026524804 |
Resistant |
| ENSG00000236432.3 |
Motesanib |
Breast invasive carcinoma |
0.034204604 |
Resistant |
| ENSG00000236463.1 |
Motesanib |
Breast invasive carcinoma |
0.044085237 |
Resistant |
| ENSG00000236869.1 |
Motesanib |
Breast invasive carcinoma |
0.046183283 |
Resistant |
| ENSG00000238280.1 |
Motesanib |
Breast invasive carcinoma |
0.031939695 |
Resistant |
| ENSG00000240086.1 |
Motesanib |
Breast invasive carcinoma |
0.049981864 |
Resistant |
| ENSG00000241219.1 |
Motesanib |
Breast invasive carcinoma |
0.023510258 |
Resistant |
| ENSG00000241481.2 |
Motesanib |
Breast invasive carcinoma |
0.014257411 |
Resistant |
| ENSG00000244479.2 |
Motesanib |
Breast invasive carcinoma |
0.034204327 |
Resistant |
| ENSG00000250039.3 |
Motesanib |
Breast invasive carcinoma |
0.017622959 |
Resistant |
| ENSG00000250075.1 |
Motesanib |
Breast invasive carcinoma |
0.036391863 |
Resistant |
| ENSG00000250490.1 |
Motesanib |
Breast invasive carcinoma |
0.030081216 |
Resistant |
| ENSG00000251148.1 |
Motesanib |
Breast invasive carcinoma |
0.04932216 |
Resistant |
| ENSG00000254687.1 |
Motesanib |
Breast invasive carcinoma |
0.039066531 |
Resistant |
| ENSG00000254936.3 |
Motesanib |
Breast invasive carcinoma |
0.025027108 |
Resistant |
| ENSG00000254990.1 |
Motesanib |
Breast invasive carcinoma |
0.008092192 |
Resistant |
| ENSG00000255052.3 |
Motesanib |
Breast invasive carcinoma |
0.039325263 |
Resistant |
| ENSG00000255328.1 |
Motesanib |
Breast invasive carcinoma |
0.042279655 |
Resistant |
| ENSG00000255434.1 |
Motesanib |
Breast invasive carcinoma |
0.021738794 |
Resistant |
| ENSG00000259172.1 |
Motesanib |
Breast invasive carcinoma |
0.044637072 |
Resistant |
| ENSG00000259424.1 |
Motesanib |
Breast invasive carcinoma |
0.048057855 |
Resistant |
| ENSG00000259865.1 |
Motesanib |
Breast invasive carcinoma |
0.031403226 |
Resistant |
| ENSG00000260808.1 |
Motesanib |
Breast invasive carcinoma |
0.038267696 |
Resistant |
| ENSG00000260920.1 |
Motesanib |
Breast invasive carcinoma |
0.043459463 |
Resistant |
| ENSG00000260997.1 |
Motesanib |
Breast invasive carcinoma |
0.037646285 |
Resistant |
| ENSG00000261126.3 |
Motesanib |
Breast invasive carcinoma |
0.022574033 |
Resistant |
| ENSG00000261212.1 |
Motesanib |
Breast invasive carcinoma |
0.032213385 |
Resistant |
| ENSG00000261305.1 |
Motesanib |
Breast invasive carcinoma |
0.011823007 |
Resistant |
| ENSG00000261451.1 |
Motesanib |
Breast invasive carcinoma |
0.049602812 |
Resistant |
| ENSG00000261533.1 |
Motesanib |
Breast invasive carcinoma |
0.029853011 |
Resistant |
| ENSG00000262098.1 |
Motesanib |
Breast invasive carcinoma |
0.008790381 |
Resistant |
| ENSG00000263862.1 |
Motesanib |
Breast invasive carcinoma |
0.03019244 |
Resistant |
| ENSG00000265496.2 |
Motesanib |
Breast invasive carcinoma |
0.035550487 |
Resistant |
| ENSG00000267010.1 |
Motesanib |
Breast invasive carcinoma |
0.033932302 |
Resistant |
| ENSG00000267167.1 |
Motesanib |
Breast invasive carcinoma |
0.046300144 |
Resistant |
| ENSG00000267249.1 |
Motesanib |
Breast invasive carcinoma |
0.018146487 |
Resistant |
| ENSG00000267481.1 |
Motesanib |
Breast invasive carcinoma |
0.007954588 |
Resistant |
| ENSG00000267581.1 |
Motesanib |
Breast invasive carcinoma |
0.041961422 |
Resistant |
| ENSG00000267586.2 |
Motesanib |
Breast invasive carcinoma |
0.030840539 |
Resistant |
| ENSG00000267651.1 |
Motesanib |
Breast invasive carcinoma |
0.043711018 |
Resistant |
| ENSG00000267759.1 |
Motesanib |
Breast invasive carcinoma |
0.012260278 |
Resistant |
| ENSG00000267778.1 |
Motesanib |
Breast invasive carcinoma |
0.027066959 |
Resistant |
| ENSG00000268613.1 |
Motesanib |
Breast invasive carcinoma |
0.028659081 |
Resistant |
| ENSG00000269483.1 |
Motesanib |
Breast invasive carcinoma |
0.016397547 |
Resistant |
| ENSG00000269560.1 |
Motesanib |
Breast invasive carcinoma |
0.030188819 |
Resistant |
| ENSG00000269825.1 |
Motesanib |
Breast invasive carcinoma |
0.007853365 |
Resistant |
| ENSG00000269834.1 |
Motesanib |
Breast invasive carcinoma |
0.017333541 |
Resistant |
| ENSG00000270020.1 |
Motesanib |
Breast invasive carcinoma |
0.047629967 |
Resistant |
| ENSG00000270178.1 |
Motesanib |
Breast invasive carcinoma |
0.002740237 |
Resistant |
| ENSG00000271757.1 |
Motesanib |
Breast invasive carcinoma |
0.039008238 |
Resistant |
| ENSG00000272077.1 |
Motesanib |
Breast invasive carcinoma |
0.019758946 |
Resistant |
| ENSG00000272308.1 |
Motesanib |
Breast invasive carcinoma |
0.01473027 |
Resistant |
| ENSG00000272377.1 |
Motesanib |
Breast invasive carcinoma |
0.004579662 |
Resistant |
| ENSG00000272505.1 |
Motesanib |
Breast invasive carcinoma |
0.044883677 |
Resistant |
| ENSG00000272885.1 |
Motesanib |
Breast invasive carcinoma |
0.020512241 |
Resistant |
| ENSG00000272895.1 |
Motesanib |
Breast invasive carcinoma |
0.048609359 |
Resistant |
| ENSG00000272913.1 |
Motesanib |
Breast invasive carcinoma |
0.024921228 |
Resistant |
| ENSG00000273011.1 |
Motesanib |
Breast invasive carcinoma |
0.043692642 |
Resistant |
| ENSG00000184068.2 |
Motesanib |
Colon adenocarcinoma |
0.009067186 |
Resistant |
| ENSG00000185186.4 |
Motesanib |
Colon adenocarcinoma |
0.046595988 |
Resistant |
| ENSG00000196553.9 |
Motesanib |
Colon adenocarcinoma |
0.002308159 |
Resistant |
| ENSG00000203601.3 |
Motesanib |
Colon adenocarcinoma |
0.038164929 |
Resistant |
| ENSG00000203635.2 |
Motesanib |
Colon adenocarcinoma |
0.024026268 |
Resistant |
| ENSG00000223546.2 |
Motesanib |
Colon adenocarcinoma |
0.035028903 |
Resistant |
| ENSG00000224100.1 |
Motesanib |
Colon adenocarcinoma |
0.034754409 |
Resistant |
| ENSG00000225146.1 |
Motesanib |
Colon adenocarcinoma |
0.018553632 |
Resistant |
| ENSG00000225470.2 |
Motesanib |
Colon adenocarcinoma |
0.010632339 |
Resistant |
| ENSG00000225643.1 |
Motesanib |
Colon adenocarcinoma |
0.012645531 |
Resistant |
| ENSG00000225791.2 |
Motesanib |
Colon adenocarcinoma |
0.026979914 |
Resistant |
| ENSG00000226386.1 |
Motesanib |
Colon adenocarcinoma |
0.045342257 |
Resistant |
| ENSG00000227896.2 |
Motesanib |
Colon adenocarcinoma |
0.049616376 |
Resistant |
| ENSG00000228436.2 |
Motesanib |
Colon adenocarcinoma |
0.003093439 |
Resistant |
| ENSG00000228486.5 |
Motesanib |
Colon adenocarcinoma |
0.022609228 |
Resistant |
| ENSG00000228527.1 |
Motesanib |
Colon adenocarcinoma |
0.037336472 |
Resistant |
| ENSG00000228613.1 |
Motesanib |
Colon adenocarcinoma |
0.030109283 |
Resistant |
| ENSG00000228686.2 |
Motesanib |
Colon adenocarcinoma |
0.010502632 |
Resistant |
| ENSG00000229263.1 |
Motesanib |
Colon adenocarcinoma |
0.034067156 |
Resistant |
| ENSG00000229728.1 |
Motesanib |
Colon adenocarcinoma |
0.048132293 |
Resistant |
| ENSG00000230061.1 |
Motesanib |
Colon adenocarcinoma |
0.011538504 |
Resistant |
| ENSG00000230289.1 |
Motesanib |
Colon adenocarcinoma |
0.003711554 |
Resistant |
| ENSG00000230530.1 |
Motesanib |
Colon adenocarcinoma |
0.024316634 |
Resistant |
| ENSG00000230679.1 |
Motesanib |
Colon adenocarcinoma |
0.045149406 |
Resistant |
| ENSG00000230896.1 |
Motesanib |
Colon adenocarcinoma |
0.014963847 |
Resistant |
| ENSG00000231365.1 |
Motesanib |
Colon adenocarcinoma |
0.034797426 |
Resistant |
| ENSG00000231521.1 |
Motesanib |
Colon adenocarcinoma |
0.029723278 |
Resistant |
| ENSG00000231704.1 |
Motesanib |
Colon adenocarcinoma |
0.019590918 |
Resistant |
| ENSG00000232160.2 |
Motesanib |
Colon adenocarcinoma |
0.03330911 |
Resistant |
| ENSG00000232593.2 |
Motesanib |
Colon adenocarcinoma |
0.030526028 |
Resistant |
| ENSG00000233246.1 |
Motesanib |
Colon adenocarcinoma |
0.000869629 |
Resistant |
| ENSG00000233360.4 |
Motesanib |
Colon adenocarcinoma |
0.007937793 |
Resistant |
| ENSG00000233509.2 |
Motesanib |
Colon adenocarcinoma |
0.03174918 |
Resistant |
| ENSG00000234062.3 |
Motesanib |
Colon adenocarcinoma |
0.046419456 |
Resistant |
| ENSG00000234232.2 |
Motesanib |
Colon adenocarcinoma |
0.013110185 |
Resistant |
| ENSG00000234608.3 |
Motesanib |
Colon adenocarcinoma |
0.014956462 |
Resistant |
| ENSG00000234684.2 |
Motesanib |
Colon adenocarcinoma |
0.04327989 |
Resistant |
| ENSG00000235204.1 |
Motesanib |
Colon adenocarcinoma |
0.030910141 |
Resistant |
| ENSG00000235927.2 |
Motesanib |
Colon adenocarcinoma |
0.028229597 |
Resistant |
| ENSG00000236088.5 |
Motesanib |
Colon adenocarcinoma |
0.009943116 |
Resistant |
| ENSG00000237343.1 |
Motesanib |
Colon adenocarcinoma |
0.038552286 |
Resistant |
| ENSG00000237429.1 |
Motesanib |
Colon adenocarcinoma |
0.020903183 |
Resistant |
| ENSG00000237738.1 |
Motesanib |
Colon adenocarcinoma |
0.025824001 |
Resistant |
| ENSG00000237945.3 |
Motesanib |
Colon adenocarcinoma |
0.01699764 |
Resistant |
| ENSG00000237978.1 |
Motesanib |
Colon adenocarcinoma |
0.034047707 |
Resistant |
| ENSG00000239608.1 |
Motesanib |
Colon adenocarcinoma |
0.042336304 |
Resistant |
| ENSG00000244791.2 |
Motesanib |
Colon adenocarcinoma |
0.033194573 |
Resistant |
| ENSG00000244952.2 |
Motesanib |
Colon adenocarcinoma |
0.03642027 |
Resistant |
| ENSG00000245293.2 |
Motesanib |
Colon adenocarcinoma |
0.026357002 |
Resistant |
| ENSG00000245498.2 |
Motesanib |
Colon adenocarcinoma |
0.041288258 |
Resistant |
| ENSG00000245534.2 |
Motesanib |
Colon adenocarcinoma |
0.013025284 |
Resistant |
| ENSG00000245975.2 |
Motesanib |
Colon adenocarcinoma |
0.049090685 |
Resistant |
| ENSG00000246308.1 |
Motesanib |
Colon adenocarcinoma |
0.048213327 |
Resistant |
| ENSG00000246582.2 |
Motesanib |
Colon adenocarcinoma |
0.039461028 |
Resistant |
| ENSG00000247199.3 |
Motesanib |
Colon adenocarcinoma |
0.032608207 |
Resistant |
| ENSG00000247271.2 |
Motesanib |
Colon adenocarcinoma |
0.025719274 |
Resistant |
| ENSG00000247498.5 |
Motesanib |
Colon adenocarcinoma |
0.031715482 |
Resistant |
| ENSG00000247556.2 |
Motesanib |
Colon adenocarcinoma |
0.029435712 |
Resistant |
| ENSG00000247877.2 |
Motesanib |
Colon adenocarcinoma |
0.041088167 |
Resistant |
| ENSG00000248019.2 |
Motesanib |
Colon adenocarcinoma |
0.03902746 |
Resistant |
| ENSG00000248468.1 |
Motesanib |
Colon adenocarcinoma |
0.04816119 |
Resistant |
| ENSG00000249898.3 |
Motesanib |
Colon adenocarcinoma |
0.025062181 |
Resistant |
| ENSG00000250081.1 |
Motesanib |
Colon adenocarcinoma |
0.017985452 |
Resistant |
| ENSG00000250541.1 |
Motesanib |
Colon adenocarcinoma |
0.039179013 |
Resistant |
| ENSG00000250714.3 |
Motesanib |
Colon adenocarcinoma |
0.023987324 |
Resistant |
| ENSG00000251026.1 |
Motesanib |
Colon adenocarcinoma |
0.029423809 |
Resistant |
| ENSG00000251455.1 |
Motesanib |
Colon adenocarcinoma |
0.045949878 |
Resistant |
| ENSG00000251603.1 |
Motesanib |
Colon adenocarcinoma |
0.017052182 |
Resistant |
| ENSG00000253764.1 |
Motesanib |
Colon adenocarcinoma |
0.045834901 |
Resistant |
| ENSG00000253982.1 |
Motesanib |
Colon adenocarcinoma |
0.036340809 |
Resistant |
| ENSG00000254153.1 |
Motesanib |
Colon adenocarcinoma |
0.034773012 |
Resistant |
| ENSG00000254560.1 |
Motesanib |
Colon adenocarcinoma |
0.032314013 |
Resistant |
| ENSG00000254731.1 |
Motesanib |
Colon adenocarcinoma |
0.025542061 |
Resistant |
| ENSG00000254826.1 |
Motesanib |
Colon adenocarcinoma |
0.04149208 |
Resistant |
| ENSG00000254991.1 |
Motesanib |
Colon adenocarcinoma |
0.035793447 |
Resistant |
| ENSG00000255495.1 |
Motesanib |
Colon adenocarcinoma |
0.015479016 |
Resistant |
| ENSG00000255651.2 |
Motesanib |
Colon adenocarcinoma |
0.009573881 |
Resistant |
| ENSG00000255669.1 |
Motesanib |
Colon adenocarcinoma |
0.03289574 |
Resistant |
| ENSG00000257410.1 |
Motesanib |
Colon adenocarcinoma |
0.004893182 |
Resistant |
| ENSG00000257433.1 |
Motesanib |
Colon adenocarcinoma |
0.048876869 |
Resistant |
| ENSG00000258101.1 |
Motesanib |
Colon adenocarcinoma |
0.002384103 |
Resistant |
| ENSG00000258260.1 |
Motesanib |
Colon adenocarcinoma |
0.049835698 |
Resistant |
| ENSG00000258442.1 |
Motesanib |
Colon adenocarcinoma |
0.037054317 |
Resistant |
| ENSG00000258777.1 |
Motesanib |
Colon adenocarcinoma |
0.026053827 |
Resistant |
| ENSG00000259198.1 |
Motesanib |
Colon adenocarcinoma |
0.031746912 |
Resistant |
| ENSG00000259341.1 |
Motesanib |
Colon adenocarcinoma |
0.034535785 |
Resistant |
| ENSG00000259366.1 |
Motesanib |
Colon adenocarcinoma |
0.020250231 |
Resistant |
| ENSG00000259540.1 |
Motesanib |
Colon adenocarcinoma |
0.003165687 |
Resistant |
| ENSG00000259673.1 |
Motesanib |
Colon adenocarcinoma |
0.036839476 |
Resistant |
| ENSG00000259901.1 |
Motesanib |
Colon adenocarcinoma |
0.035368502 |
Resistant |
| ENSG00000260269.1 |
Motesanib |
Colon adenocarcinoma |
0.019385768 |
Resistant |
| ENSG00000260273.1 |
Motesanib |
Colon adenocarcinoma |
0.043150965 |
Resistant |
| ENSG00000260630.2 |
Motesanib |
Colon adenocarcinoma |
0.000703357 |
Resistant |
| ENSG00000260954.1 |
Motesanib |
Colon adenocarcinoma |
0.034786688 |
Resistant |
| ENSG00000261008.2 |
Motesanib |
Colon adenocarcinoma |
0.044514477 |
Resistant |
| ENSG00000261172.1 |
Motesanib |
Colon adenocarcinoma |
0.012876448 |
Resistant |
| ENSG00000261476.1 |
Motesanib |
Colon adenocarcinoma |
0.035038575 |
Resistant |
| ENSG00000261534.1 |
Motesanib |
Colon adenocarcinoma |
0.023403692 |
Resistant |
| ENSG00000261775.1 |
Motesanib |
Colon adenocarcinoma |
0.024526777 |
Resistant |
| ENSG00000261798.1 |
Motesanib |
Colon adenocarcinoma |
0.021321279 |
Resistant |
| ENSG00000262147.1 |
Motesanib |
Colon adenocarcinoma |
0.032289283 |
Resistant |
| ENSG00000262514.1 |
Motesanib |
Colon adenocarcinoma |
0.030204995 |
Resistant |
| ENSG00000262692.1 |
Motesanib |
Colon adenocarcinoma |
0.042529872 |
Resistant |
| ENSG00000262879.1 |
Motesanib |
Colon adenocarcinoma |
0.049802278 |
Resistant |
| ENSG00000263004.1 |
Motesanib |
Colon adenocarcinoma |
0.019594603 |
Resistant |
| ENSG00000264222.1 |
Motesanib |
Colon adenocarcinoma |
0.01676046 |
Resistant |
| ENSG00000264885.1 |
Motesanib |
Colon adenocarcinoma |
0.018840768 |
Resistant |
| ENSG00000265349.1 |
Motesanib |
Colon adenocarcinoma |
0.001831804 |
Resistant |
| ENSG00000265490.1 |
Motesanib |
Colon adenocarcinoma |
0.026882495 |
Resistant |
| ENSG00000266473.1 |
Motesanib |
Colon adenocarcinoma |
0.015750996 |
Resistant |
| ENSG00000266869.1 |
Motesanib |
Colon adenocarcinoma |
0.026844419 |
Resistant |
| ENSG00000266993.1 |
Motesanib |
Colon adenocarcinoma |
0.015481295 |
Resistant |
| ENSG00000267064.1 |
Motesanib |
Colon adenocarcinoma |
0.038590511 |
Resistant |
| ENSG00000267481.1 |
Motesanib |
Colon adenocarcinoma |
0.032067376 |
Resistant |
| ENSG00000267560.1 |
Motesanib |
Colon adenocarcinoma |
0.030877031 |
Resistant |
| ENSG00000268189.2 |
Motesanib |
Colon adenocarcinoma |
0.046113604 |
Resistant |
| ENSG00000268605.1 |
Motesanib |
Colon adenocarcinoma |
0.01387072 |
Resistant |
| ENSG00000269191.1 |
Motesanib |
Colon adenocarcinoma |
0.036690345 |
Resistant |
| ENSG00000269609.1 |
Motesanib |
Colon adenocarcinoma |
0.036557052 |
Resistant |
| ENSG00000269646.1 |
Motesanib |
Colon adenocarcinoma |
0.013938962 |
Resistant |
| ENSG00000269892.1 |
Motesanib |
Colon adenocarcinoma |
0.033624921 |
Resistant |
| ENSG00000269947.1 |
Motesanib |
Colon adenocarcinoma |
0.022428909 |
Resistant |
| ENSG00000269949.1 |
Motesanib |
Colon adenocarcinoma |
0.038207248 |
Resistant |
| ENSG00000269979.1 |
Motesanib |
Colon adenocarcinoma |
0.02129541 |
Resistant |
| ENSG00000270019.1 |
Motesanib |
Colon adenocarcinoma |
0.030835423 |
Resistant |
| ENSG00000270083.1 |
Motesanib |
Colon adenocarcinoma |
0.006800149 |
Resistant |
| ENSG00000270116.1 |
Motesanib |
Colon adenocarcinoma |
0.046928279 |
Resistant |
| ENSG00000270127.1 |
Motesanib |
Colon adenocarcinoma |
0.00422879 |
Resistant |
| ENSG00000270362.1 |
Motesanib |
Colon adenocarcinoma |
0.046537557 |
Resistant |
| ENSG00000271387.1 |
Motesanib |
Colon adenocarcinoma |
0.044808253 |
Resistant |
| ENSG00000271789.1 |
Motesanib |
Colon adenocarcinoma |
0.037549071 |
Resistant |
| ENSG00000271948.1 |
Motesanib |
Colon adenocarcinoma |
0.01159234 |
Resistant |
| ENSG00000272221.1 |
Motesanib |
Colon adenocarcinoma |
0.002660905 |
Resistant |
| ENSG00000272696.1 |
Motesanib |
Colon adenocarcinoma |
0.027360385 |
Resistant |
| ENSG00000272864.1 |
Motesanib |
Colon adenocarcinoma |
0.038512291 |
Resistant |
| ENSG00000272892.1 |
Motesanib |
Colon adenocarcinoma |
0.031438708 |
Resistant |
| ENSG00000272904.1 |
Motesanib |
Colon adenocarcinoma |
0.046542258 |
Resistant |
| ENSG00000273097.1 |
Motesanib |
Colon adenocarcinoma |
0.024297913 |
Resistant |
| ENSG00000203362.2 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01462528 |
Resistant |
| ENSG00000225555.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001528134 |
Resistant |
| ENSG00000225579.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028969392 |
Resistant |
| ENSG00000226287.3 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007610367 |
Resistant |
| ENSG00000227373.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021755051 |
Resistant |
| ENSG00000228005.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033612263 |
Resistant |
| ENSG00000236137.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002399395 |
Resistant |
| ENSG00000236682.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042107245 |
Resistant |
| ENSG00000239569.2 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041658683 |
Resistant |
| ENSG00000243637.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027805572 |
Resistant |
| ENSG00000254682.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017404032 |
Resistant |
| ENSG00000264270.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035504671 |
Resistant |
| ENSG00000266978.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027269188 |
Resistant |
| ENSG00000272677.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032505944 |
Resistant |
| ENSG00000272808.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014503124 |
Resistant |
| ENSG00000273313.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022503205 |
Resistant |
| ENSG00000228598.1 |
Motesanib |
Esophageal cancer |
0.039502338 |
Resistant |
| ENSG00000231711.2 |
Motesanib |
Esophageal cancer |
0.033164141 |
Resistant |
| ENSG00000235262.1 |
Motesanib |
Esophageal cancer |
0.011421046 |
Resistant |
| ENSG00000253372.1 |
Motesanib |
Esophageal cancer |
0.03995245 |
Resistant |
| ENSG00000253930.1 |
Motesanib |
Esophageal cancer |
0.047680093 |
Resistant |
| ENSG00000254153.1 |
Motesanib |
Esophageal cancer |
0.044453126 |
Resistant |
| ENSG00000261295.1 |
Motesanib |
Esophageal cancer |
0.043402028 |
Resistant |
| ENSG00000269321.1 |
Motesanib |
Esophageal cancer |
0.042813004 |
Resistant |
| ENSG00000272913.1 |
Motesanib |
Esophageal cancer |
0.035229044 |
Resistant |
| ENSG00000273311.1 |
Motesanib |
Esophageal cancer |
0.032653901 |
Resistant |
| ENSG00000196972.6 |
Motesanib |
Brain lower grade glioma |
0.034581029 |
Resistant |
| ENSG00000214922.5 |
Motesanib |
Brain lower grade glioma |
0.017835942 |
Resistant |
| ENSG00000223414.2 |
Motesanib |
Brain lower grade glioma |
0.039658183 |
Resistant |
| ENSG00000223573.2 |
Motesanib |
Brain lower grade glioma |
0.02004554 |
Resistant |
| ENSG00000223935.1 |
Motesanib |
Brain lower grade glioma |
0.014488419 |
Resistant |
| ENSG00000225798.1 |
Motesanib |
Brain lower grade glioma |
0.008230269 |
Resistant |
| ENSG00000225981.1 |
Motesanib |
Brain lower grade glioma |
0.049314975 |
Resistant |
| ENSG00000226302.1 |
Motesanib |
Brain lower grade glioma |
0.019220034 |
Resistant |
| ENSG00000226375.1 |
Motesanib |
Brain lower grade glioma |
0.045736924 |
Resistant |
| ENSG00000227014.1 |
Motesanib |
Brain lower grade glioma |
0.027403062 |
Resistant |
| ENSG00000228317.1 |
Motesanib |
Brain lower grade glioma |
0.034637085 |
Resistant |
| ENSG00000229512.1 |
Motesanib |
Brain lower grade glioma |
0.048922485 |
Resistant |
| ENSG00000230054.1 |
Motesanib |
Brain lower grade glioma |
0.011412639 |
Resistant |
| ENSG00000231789.2 |
Motesanib |
Brain lower grade glioma |
0.041085583 |
Resistant |
| ENSG00000232259.1 |
Motesanib |
Brain lower grade glioma |
0.027215695 |
Resistant |
| ENSG00000232536.1 |
Motesanib |
Brain lower grade glioma |
0.017834885 |
Resistant |
| ENSG00000233203.2 |
Motesanib |
Brain lower grade glioma |
0.022458203 |
Resistant |
| ENSG00000234210.1 |
Motesanib |
Brain lower grade glioma |
0.023995246 |
Resistant |
| ENSG00000234263.1 |
Motesanib |
Brain lower grade glioma |
0.022330762 |
Resistant |
| ENSG00000234393.1 |
Motesanib |
Brain lower grade glioma |
0.02285398 |
Resistant |
| ENSG00000236472.1 |
Motesanib |
Brain lower grade glioma |
0.012229472 |
Resistant |
| ENSG00000236526.1 |
Motesanib |
Brain lower grade glioma |
0.034689873 |
Resistant |
| ENSG00000236581.4 |
Motesanib |
Brain lower grade glioma |
0.025948516 |
Resistant |
| ENSG00000236936.1 |
Motesanib |
Brain lower grade glioma |
0.037887265 |
Resistant |
| ENSG00000242396.1 |
Motesanib |
Brain lower grade glioma |
0.003911805 |
Resistant |
| ENSG00000245526.4 |
Motesanib |
Brain lower grade glioma |
0.044383478 |
Resistant |
| ENSG00000246334.2 |
Motesanib |
Brain lower grade glioma |
0.021911577 |
Resistant |
| ENSG00000246863.2 |
Motesanib |
Brain lower grade glioma |
0.009535612 |
Resistant |
| ENSG00000249216.1 |
Motesanib |
Brain lower grade glioma |
0.027022125 |
Resistant |
| ENSG00000249453.1 |
Motesanib |
Brain lower grade glioma |
0.024454399 |
Resistant |
| ENSG00000250222.1 |
Motesanib |
Brain lower grade glioma |
0.033853525 |
Resistant |
| ENSG00000251460.1 |
Motesanib |
Brain lower grade glioma |
0.016970867 |
Resistant |
| ENSG00000254275.2 |
Motesanib |
Brain lower grade glioma |
0.049865452 |
Resistant |
| ENSG00000255322.1 |
Motesanib |
Brain lower grade glioma |
0.029042077 |
Resistant |
| ENSG00000256124.1 |
Motesanib |
Brain lower grade glioma |
0.030388693 |
Resistant |
| ENSG00000257202.1 |
Motesanib |
Brain lower grade glioma |
0.049429591 |
Resistant |
| ENSG00000257285.1 |
Motesanib |
Brain lower grade glioma |
0.027035606 |
Resistant |
| ENSG00000257808.1 |
Motesanib |
Brain lower grade glioma |
0.004746448 |
Resistant |
| ENSG00000258919.1 |
Motesanib |
Brain lower grade glioma |
0.019988909 |
Resistant |
| ENSG00000259628.1 |
Motesanib |
Brain lower grade glioma |
0.014550673 |
Resistant |
| ENSG00000260810.1 |
Motesanib |
Brain lower grade glioma |
0.045309626 |
Resistant |
| ENSG00000260891.1 |
Motesanib |
Brain lower grade glioma |
0.047348729 |
Resistant |
| ENSG00000261114.1 |
Motesanib |
Brain lower grade glioma |
0.001096236 |
Resistant |
| ENSG00000261270.1 |
Motesanib |
Brain lower grade glioma |
0.008343656 |
Resistant |
| ENSG00000261513.1 |
Motesanib |
Brain lower grade glioma |
0.042066464 |
Resistant |
| ENSG00000262171.1 |
Motesanib |
Brain lower grade glioma |
0.036728878 |
Resistant |
| ENSG00000262339.1 |
Motesanib |
Brain lower grade glioma |
0.038677693 |
Resistant |
| ENSG00000263470.1 |
Motesanib |
Brain lower grade glioma |
0.041748482 |
Resistant |
| ENSG00000263680.2 |
Motesanib |
Brain lower grade glioma |
0.042015467 |
Resistant |
| ENSG00000264546.1 |
Motesanib |
Brain lower grade glioma |
0.049192155 |
Resistant |
| ENSG00000265479.1 |
Motesanib |
Brain lower grade glioma |
0.016679867 |
Resistant |
| ENSG00000267082.1 |
Motesanib |
Brain lower grade glioma |
0.040180372 |
Resistant |
| ENSG00000267175.1 |
Motesanib |
Brain lower grade glioma |
0.014277219 |
Resistant |
| ENSG00000267279.1 |
Motesanib |
Brain lower grade glioma |
0.042606254 |
Resistant |
| ENSG00000267547.1 |
Motesanib |
Brain lower grade glioma |
0.03906929 |
Resistant |
| ENSG00000267711.1 |
Motesanib |
Brain lower grade glioma |
0.040770827 |
Resistant |
| ENSG00000269967.1 |
Motesanib |
Brain lower grade glioma |
0.039237913 |
Resistant |
| ENSG00000270116.1 |
Motesanib |
Brain lower grade glioma |
0.047555646 |
Resistant |
| ENSG00000271780.1 |
Motesanib |
Brain lower grade glioma |
0.027397738 |
Resistant |
| ENSG00000272123.1 |
Motesanib |
Brain lower grade glioma |
0.028191268 |
Resistant |
| ENSG00000272382.1 |
Motesanib |
Brain lower grade glioma |
0.040469736 |
Resistant |
| ENSG00000272695.1 |
Motesanib |
Brain lower grade glioma |
0.043979897 |
Resistant |
| ENSG00000272950.1 |
Motesanib |
Brain lower grade glioma |
0.046573659 |
Resistant |
| ENSG00000273328.1 |
Motesanib |
Brain lower grade glioma |
0.027550009 |
Resistant |
| ENSG00000224167.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.005927448 |
Resistant |
| ENSG00000225213.2 |
Motesanib |
Liver hepatocellular carcinoma |
0.023218663 |
Resistant |
| ENSG00000229444.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.037816644 |
Resistant |
| ENSG00000231999.2 |
Motesanib |
Liver hepatocellular carcinoma |
0.029248174 |
Resistant |
| ENSG00000235475.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.013751897 |
Resistant |
| ENSG00000238197.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.010017592 |
Resistant |
| ENSG00000245662.2 |
Motesanib |
Liver hepatocellular carcinoma |
0.020183461 |
Resistant |
| ENSG00000246263.2 |
Motesanib |
Liver hepatocellular carcinoma |
0.00868185 |
Resistant |
| ENSG00000250132.2 |
Motesanib |
Liver hepatocellular carcinoma |
0.025004532 |
Resistant |
| ENSG00000257718.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.028908405 |
Resistant |
| ENSG00000261451.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.011976961 |
Resistant |
| ENSG00000261824.2 |
Motesanib |
Liver hepatocellular carcinoma |
0.035069208 |
Resistant |
| ENSG00000265845.2 |
Motesanib |
Liver hepatocellular carcinoma |
0.005783256 |
Resistant |
| ENSG00000267798.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.02329343 |
Resistant |
| ENSG00000269983.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.012278422 |
Resistant |
| ENSG00000271912.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.006198191 |
Resistant |
| ENSG00000272226.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.039143463 |
Resistant |
| ENSG00000272914.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.024859612 |
Resistant |
| ENSG00000272966.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.049009702 |
Resistant |
| ENSG00000223642.3 |
Motesanib |
Lung squamous cell carcinoma |
0.022471395 |
Resistant |
| ENSG00000230751.1 |
Motesanib |
Lung squamous cell carcinoma |
0.011730465 |
Resistant |
| ENSG00000241135.1 |
Motesanib |
Lung squamous cell carcinoma |
0.045088332 |
Resistant |
| ENSG00000241886.1 |
Motesanib |
Lung squamous cell carcinoma |
0.042087507 |
Resistant |
| ENSG00000254879.1 |
Motesanib |
Lung squamous cell carcinoma |
0.013155354 |
Resistant |
| ENSG00000255565.1 |
Motesanib |
Lung squamous cell carcinoma |
0.039219609 |
Resistant |
| ENSG00000258303.1 |
Motesanib |
Lung squamous cell carcinoma |
0.016573565 |
Resistant |
| ENSG00000259163.1 |
Motesanib |
Lung squamous cell carcinoma |
0.033496749 |
Resistant |
| ENSG00000269934.1 |
Motesanib |
Lung squamous cell carcinoma |
0.042169589 |
Resistant |
| ENSG00000271420.1 |
Motesanib |
Lung squamous cell carcinoma |
0.030451038 |
Resistant |
| ENSG00000272610.1 |
Motesanib |
Lung squamous cell carcinoma |
0.027758255 |
Resistant |
| ENSG00000186369.5 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034353265 |
Resistant |
| ENSG00000197989.9 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044387127 |
Resistant |
| ENSG00000215039.2 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033620214 |
Resistant |
| ENSG00000224945.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013482954 |
Resistant |
| ENSG00000231025.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04777937 |
Resistant |
| ENSG00000234741.3 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028148296 |
Resistant |
| ENSG00000235236.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013845324 |
Resistant |
| ENSG00000236308.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007256513 |
Resistant |
| ENSG00000237975.2 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040830632 |
Resistant |
| ENSG00000249859.3 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014782232 |
Resistant |
| ENSG00000259799.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048166383 |
Resistant |
| ENSG00000261695.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039443449 |
Resistant |
| ENSG00000266651.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.004160186 |
Resistant |
| ENSG00000267249.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.010750936 |
Resistant |
| ENSG00000268518.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009482174 |
Resistant |
| ENSG00000270109.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043842776 |
Resistant |
| ENSG00000271964.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017362107 |
Resistant |
| ENSG00000272828.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.0341622 |
Resistant |
| ENSG00000273165.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032346782 |
Resistant |
| ENSG00000273176.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006419479 |
Resistant |
| ENSG00000223528.3 |
Motesanib |
Pancreatic adenocarcinoma |
0.040835442 |
Resistant |
| ENSG00000226310.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.021647224 |
Resistant |
| ENSG00000226876.2 |
Motesanib |
Pancreatic adenocarcinoma |
0.016216615 |
Resistant |
| ENSG00000231401.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.048066833 |
Resistant |
| ENSG00000233501.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.028382718 |
Resistant |
| ENSG00000237328.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.026272016 |
Resistant |
| ENSG00000240907.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.0324764 |
Resistant |
| ENSG00000250842.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.004847883 |
Resistant |
| ENSG00000257953.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.035021506 |
Resistant |
| ENSG00000260059.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.017014613 |
Resistant |
| ENSG00000263893.2 |
Motesanib |
Pancreatic adenocarcinoma |
0.039908477 |
Resistant |
| ENSG00000270022.2 |
Motesanib |
Pancreatic adenocarcinoma |
0.013975442 |
Resistant |
| ENSG00000203506.3 |
Motesanib |
Sarcoma |
0.028209192 |
Resistant |
| ENSG00000223652.2 |
Motesanib |
Sarcoma |
0.012842576 |
Resistant |
| ENSG00000224764.1 |
Motesanib |
Sarcoma |
0.012983362 |
Resistant |
| ENSG00000225300.1 |
Motesanib |
Sarcoma |
0.049586323 |
Resistant |
| ENSG00000227256.1 |
Motesanib |
Sarcoma |
0.021373158 |
Resistant |
| ENSG00000227431.1 |
Motesanib |
Sarcoma |
0.025828864 |
Resistant |
| ENSG00000228352.2 |
Motesanib |
Sarcoma |
0.048948437 |
Resistant |
| ENSG00000229021.2 |
Motesanib |
Sarcoma |
0.016729578 |
Resistant |
| ENSG00000229065.1 |
Motesanib |
Sarcoma |
0.012752466 |
Resistant |
| ENSG00000229780.1 |
Motesanib |
Sarcoma |
0.005668513 |
Resistant |
| ENSG00000230648.1 |
Motesanib |
Sarcoma |
0.010055684 |
Resistant |
| ENSG00000230922.1 |
Motesanib |
Sarcoma |
0.043643016 |
Resistant |
| ENSG00000231764.4 |
Motesanib |
Sarcoma |
0.012989104 |
Resistant |
| ENSG00000232455.2 |
Motesanib |
Sarcoma |
0.038761232 |
Resistant |
| ENSG00000232593.2 |
Motesanib |
Sarcoma |
0.005937391 |
Resistant |
| ENSG00000232721.1 |
Motesanib |
Sarcoma |
0.044336963 |
Resistant |
| ENSG00000233250.1 |
Motesanib |
Sarcoma |
0.000818447 |
Resistant |
| ENSG00000233661.1 |
Motesanib |
Sarcoma |
0.000965715 |
Resistant |
| ENSG00000234019.1 |
Motesanib |
Sarcoma |
0.02661862 |
Resistant |
| ENSG00000234869.1 |
Motesanib |
Sarcoma |
0.024483607 |
Resistant |
| ENSG00000234913.1 |
Motesanib |
Sarcoma |
0.040023575 |
Resistant |
| ENSG00000235027.1 |
Motesanib |
Sarcoma |
0.021083527 |
Resistant |
| ENSG00000235772.1 |
Motesanib |
Sarcoma |
0.031790641 |
Resistant |
| ENSG00000236869.1 |
Motesanib |
Sarcoma |
0.007059387 |
Resistant |
| ENSG00000236986.2 |
Motesanib |
Sarcoma |
0.020128057 |
Resistant |
| ENSG00000237336.1 |
Motesanib |
Sarcoma |
0.003258095 |
Resistant |
| ENSG00000237343.1 |
Motesanib |
Sarcoma |
0.021127133 |
Resistant |
| ENSG00000237594.2 |
Motesanib |
Sarcoma |
0.002074251 |
Resistant |
| ENSG00000241770.1 |
Motesanib |
Sarcoma |
0.010632666 |
Resistant |
| ENSG00000245322.2 |
Motesanib |
Sarcoma |
0.01726283 |
Resistant |
| ENSG00000248473.1 |
Motesanib |
Sarcoma |
0.046197957 |
Resistant |
| ENSG00000248693.1 |
Motesanib |
Sarcoma |
0.014148016 |
Resistant |
| ENSG00000253475.1 |
Motesanib |
Sarcoma |
0.017983535 |
Resistant |
| ENSG00000254233.1 |
Motesanib |
Sarcoma |
0.006169406 |
Resistant |
| ENSG00000255366.1 |
Motesanib |
Sarcoma |
0.03294636 |
Resistant |
| ENSG00000255968.1 |
Motesanib |
Sarcoma |
0.002969099 |
Resistant |
| ENSG00000256250.1 |
Motesanib |
Sarcoma |
0.019189486 |
Resistant |
| ENSG00000258044.1 |
Motesanib |
Sarcoma |
0.001420836 |
Resistant |
| ENSG00000258378.1 |
Motesanib |
Sarcoma |
0.000977142 |
Resistant |
| ENSG00000259062.1 |
Motesanib |
Sarcoma |
0.028840488 |
Resistant |
| ENSG00000259520.1 |
Motesanib |
Sarcoma |
0.02695077 |
Resistant |
| ENSG00000259921.1 |
Motesanib |
Sarcoma |
0.026711849 |
Resistant |
| ENSG00000260831.1 |
Motesanib |
Sarcoma |
0.02289861 |
Resistant |
| ENSG00000261002.1 |
Motesanib |
Sarcoma |
0.005060759 |
Resistant |
| ENSG00000261204.1 |
Motesanib |
Sarcoma |
0.021355865 |
Resistant |
| ENSG00000261600.1 |
Motesanib |
Sarcoma |
0.000263894 |
Resistant |
| ENSG00000261673.1 |
Motesanib |
Sarcoma |
0.008155924 |
Resistant |
| ENSG00000264125.1 |
Motesanib |
Sarcoma |
0.001479234 |
Resistant |
| ENSG00000264635.1 |
Motesanib |
Sarcoma |
0.016870869 |
Resistant |
| ENSG00000264812.1 |
Motesanib |
Sarcoma |
0.00718396 |
Resistant |
| ENSG00000265342.1 |
Motesanib |
Sarcoma |
0.049671641 |
Resistant |
| ENSG00000265458.1 |
Motesanib |
Sarcoma |
0.000293104 |
Resistant |
| ENSG00000265908.1 |
Motesanib |
Sarcoma |
0.043245929 |
Resistant |
| ENSG00000266921.1 |
Motesanib |
Sarcoma |
0.040353206 |
Resistant |
| ENSG00000268520.1 |
Motesanib |
Sarcoma |
0.042353877 |
Resistant |
| ENSG00000269161.1 |
Motesanib |
Sarcoma |
0.019290432 |
Resistant |
| ENSG00000270068.1 |
Motesanib |
Sarcoma |
0.008759969 |
Resistant |
| ENSG00000271127.1 |
Motesanib |
Sarcoma |
0.0001434 |
Resistant |
| ENSG00000272529.1 |
Motesanib |
Sarcoma |
0.02007103 |
Resistant |
| ENSG00000273035.1 |
Motesanib |
Sarcoma |
0.000322593 |
Resistant |
| ENSG00000273165.1 |
Motesanib |
Sarcoma |
0.002149478 |
Resistant |
| ENSG00000273295.1 |
Motesanib |
Sarcoma |
0.02106047 |
Resistant |
| ENSG00000273369.1 |
Motesanib |
Sarcoma |
0.048129312 |
Resistant |
| ENSG00000273486.1 |
Motesanib |
Sarcoma |
0.000993737 |
Resistant |
| ENSG00000204934.6 |
Motesanib |
Skin cutaneous melanoma |
0.049153323 |
Resistant |
| ENSG00000212552.2 |
Motesanib |
Skin cutaneous melanoma |
0.022032034 |
Resistant |
| ENSG00000223561.2 |
Motesanib |
Skin cutaneous melanoma |
0.030164365 |
Resistant |
| ENSG00000223884.1 |
Motesanib |
Skin cutaneous melanoma |
0.005643293 |
Resistant |
| ENSG00000224745.1 |
Motesanib |
Skin cutaneous melanoma |
0.013561934 |
Resistant |
| ENSG00000225084.1 |
Motesanib |
Skin cutaneous melanoma |
0.011522414 |
Resistant |
| ENSG00000225195.2 |
Motesanib |
Skin cutaneous melanoma |
0.036636733 |
Resistant |
| ENSG00000225278.3 |
Motesanib |
Skin cutaneous melanoma |
0.0475984 |
Resistant |
| ENSG00000225439.2 |
Motesanib |
Skin cutaneous melanoma |
0.006829919 |
Resistant |
| ENSG00000227197.1 |
Motesanib |
Skin cutaneous melanoma |
0.030345216 |
Resistant |
| ENSG00000227210.1 |
Motesanib |
Skin cutaneous melanoma |
0.033029043 |
Resistant |
| ENSG00000227375.1 |
Motesanib |
Skin cutaneous melanoma |
0.012579536 |
Resistant |
| ENSG00000228126.1 |
Motesanib |
Skin cutaneous melanoma |
0.045044196 |
Resistant |
| ENSG00000228939.1 |
Motesanib |
Skin cutaneous melanoma |
0.023006709 |
Resistant |
| ENSG00000229688.3 |
Motesanib |
Skin cutaneous melanoma |
0.007409513 |
Resistant |
| ENSG00000229832.1 |
Motesanib |
Skin cutaneous melanoma |
0.022247452 |
Resistant |
| ENSG00000231519.1 |
Motesanib |
Skin cutaneous melanoma |
0.006507028 |
Resistant |
| ENSG00000232043.1 |
Motesanib |
Skin cutaneous melanoma |
0.039588415 |
Resistant |
| ENSG00000232455.2 |
Motesanib |
Skin cutaneous melanoma |
0.044471832 |
Resistant |
| ENSG00000232527.3 |
Motesanib |
Skin cutaneous melanoma |
0.00886904 |
Resistant |
| ENSG00000234978.1 |
Motesanib |
Skin cutaneous melanoma |
0.048254685 |
Resistant |
| ENSG00000235262.1 |
Motesanib |
Skin cutaneous melanoma |
0.007385817 |
Resistant |
| ENSG00000235522.2 |
Motesanib |
Skin cutaneous melanoma |
0.022475289 |
Resistant |
| ENSG00000236206.1 |
Motesanib |
Skin cutaneous melanoma |
0.002617303 |
Resistant |
| ENSG00000237310.1 |
Motesanib |
Skin cutaneous melanoma |
0.007065369 |
Resistant |
| ENSG00000237738.1 |
Motesanib |
Skin cutaneous melanoma |
0.030427987 |
Resistant |
| ENSG00000238261.5 |
Motesanib |
Skin cutaneous melanoma |
0.013353561 |
Resistant |
| ENSG00000239415.1 |
Motesanib |
Skin cutaneous melanoma |
0.018825219 |
Resistant |
| ENSG00000243766.3 |
Motesanib |
Skin cutaneous melanoma |
0.003936836 |
Resistant |
| ENSG00000245534.2 |
Motesanib |
Skin cutaneous melanoma |
0.017070831 |
Resistant |
| ENSG00000245648.1 |
Motesanib |
Skin cutaneous melanoma |
0.049268545 |
Resistant |
| ENSG00000249258.2 |
Motesanib |
Skin cutaneous melanoma |
0.012066242 |
Resistant |
| ENSG00000249870.1 |
Motesanib |
Skin cutaneous melanoma |
0.02504578 |
Resistant |
| ENSG00000253438.2 |
Motesanib |
Skin cutaneous melanoma |
0.043955078 |
Resistant |
| ENSG00000253515.1 |
Motesanib |
Skin cutaneous melanoma |
0.047983347 |
Resistant |
| ENSG00000253893.2 |
Motesanib |
Skin cutaneous melanoma |
0.000113768 |
Resistant |
| ENSG00000253972.1 |
Motesanib |
Skin cutaneous melanoma |
0.024676392 |
Resistant |
| ENSG00000254207.1 |
Motesanib |
Skin cutaneous melanoma |
0.002814611 |
Resistant |
| ENSG00000254688.1 |
Motesanib |
Skin cutaneous melanoma |
0.010003404 |
Resistant |
| ENSG00000254860.1 |
Motesanib |
Skin cutaneous melanoma |
0.042655317 |
Resistant |
| ENSG00000256458.1 |
Motesanib |
Skin cutaneous melanoma |
0.012662121 |
Resistant |
| ENSG00000257568.1 |
Motesanib |
Skin cutaneous melanoma |
0.042484369 |
Resistant |
| ENSG00000258285.1 |
Motesanib |
Skin cutaneous melanoma |
0.009751179 |
Resistant |
| ENSG00000258455.1 |
Motesanib |
Skin cutaneous melanoma |
0.041127212 |
Resistant |
| ENSG00000259439.1 |
Motesanib |
Skin cutaneous melanoma |
0.036963666 |
Resistant |
| ENSG00000259694.1 |
Motesanib |
Skin cutaneous melanoma |
0.028844122 |
Resistant |
| ENSG00000259783.1 |
Motesanib |
Skin cutaneous melanoma |
0.024184997 |
Resistant |
| ENSG00000259792.1 |
Motesanib |
Skin cutaneous melanoma |
0.03182609 |
Resistant |
| ENSG00000260132.1 |
Motesanib |
Skin cutaneous melanoma |
0.047829824 |
Resistant |
| ENSG00000260905.1 |
Motesanib |
Skin cutaneous melanoma |
0.047758042 |
Resistant |
| ENSG00000261033.1 |
Motesanib |
Skin cutaneous melanoma |
0.000482304 |
Resistant |
| ENSG00000261431.1 |
Motesanib |
Skin cutaneous melanoma |
0.038969566 |
Resistant |
| ENSG00000261879.1 |
Motesanib |
Skin cutaneous melanoma |
0.015333333 |
Resistant |
| ENSG00000264196.1 |
Motesanib |
Skin cutaneous melanoma |
0.024346323 |
Resistant |
| ENSG00000265206.2 |
Motesanib |
Skin cutaneous melanoma |
0.04834506 |
Resistant |
| ENSG00000266126.1 |
Motesanib |
Skin cutaneous melanoma |
0.015242204 |
Resistant |
| ENSG00000267128.1 |
Motesanib |
Skin cutaneous melanoma |
0.043525532 |
Resistant |
| ENSG00000267138.1 |
Motesanib |
Skin cutaneous melanoma |
0.015867198 |
Resistant |
| ENSG00000267272.1 |
Motesanib |
Skin cutaneous melanoma |
0.019017962 |
Resistant |
| ENSG00000269246.1 |
Motesanib |
Skin cutaneous melanoma |
0.028598978 |
Resistant |
| ENSG00000269444.1 |
Motesanib |
Skin cutaneous melanoma |
0.014742592 |
Resistant |
| ENSG00000269919.1 |
Motesanib |
Skin cutaneous melanoma |
0.013443324 |
Resistant |
| ENSG00000269950.1 |
Motesanib |
Skin cutaneous melanoma |
0.017105258 |
Resistant |
| ENSG00000270068.1 |
Motesanib |
Skin cutaneous melanoma |
0.039670799 |
Resistant |
| ENSG00000271856.1 |
Motesanib |
Skin cutaneous melanoma |
0.038947571 |
Resistant |
| ENSG00000272002.1 |
Motesanib |
Skin cutaneous melanoma |
0.027498859 |
Resistant |
| ENSG00000272346.1 |
Motesanib |
Skin cutaneous melanoma |
0.035323579 |
Resistant |
| ENSG00000272735.1 |
Motesanib |
Skin cutaneous melanoma |
0.008390149 |
Resistant |
| ENSG00000273237.1 |
Motesanib |
Skin cutaneous melanoma |
0.045958345 |
Resistant |
| ENSG00000273381.1 |
Motesanib |
Skin cutaneous melanoma |
0.013405461 |
Resistant |
| ENSG00000273406.1 |
Motesanib |
Skin cutaneous melanoma |
0.006108454 |
Resistant |
| ENSG00000224745.1 |
Motesanib |
Stomach adenocarcinoma |
0.036347174 |
Resistant |
| ENSG00000224888.3 |
Motesanib |
Stomach adenocarcinoma |
0.008077266 |
Resistant |
| ENSG00000229955.1 |
Motesanib |
Stomach adenocarcinoma |
0.009414603 |
Resistant |
| ENSG00000231102.1 |
Motesanib |
Stomach adenocarcinoma |
0.049893682 |
Resistant |
| ENSG00000236703.1 |
Motesanib |
Stomach adenocarcinoma |
0.020335776 |
Resistant |
| ENSG00000236991.2 |
Motesanib |
Stomach adenocarcinoma |
0.027351589 |
Resistant |
| ENSG00000256973.1 |
Motesanib |
Stomach adenocarcinoma |
0.01448008 |
Resistant |
| ENSG00000259540.1 |
Motesanib |
Stomach adenocarcinoma |
0.012577884 |
Resistant |
| ENSG00000260743.1 |
Motesanib |
Stomach adenocarcinoma |
0.028688885 |
Resistant |
| ENSG00000260803.1 |
Motesanib |
Stomach adenocarcinoma |
0.002574289 |
Resistant |
| ENSG00000261616.1 |
Motesanib |
Stomach adenocarcinoma |
0.028983418 |
Resistant |
| ENSG00000264112.1 |
Motesanib |
Stomach adenocarcinoma |
0.018333956 |
Resistant |
| ENSG00000265791.1 |
Motesanib |
Stomach adenocarcinoma |
0.031864497 |
Resistant |
| ENSG00000267249.1 |
Motesanib |
Stomach adenocarcinoma |
0.042423351 |
Resistant |
| ENSG00000268686.1 |
Motesanib |
Stomach adenocarcinoma |
0.02400575 |
Resistant |
| ENSG00000272219.1 |
Motesanib |
Stomach adenocarcinoma |
0.036620137 |
Resistant |
| ENSG00000214145.2 |
Motesanib |
Breast invasive carcinoma |
0.046985194 |
Sensitive |
| ENSG00000223745.3 |
Motesanib |
Breast invasive carcinoma |
0.034607244 |
Sensitive |
| ENSG00000224623.1 |
Motesanib |
Breast invasive carcinoma |
0.03218202 |
Sensitive |
| ENSG00000224855.1 |
Motesanib |
Breast invasive carcinoma |
0.026989423 |
Sensitive |
| ENSG00000224961.1 |
Motesanib |
Breast invasive carcinoma |
0.02823323 |
Sensitive |
| ENSG00000225643.1 |
Motesanib |
Breast invasive carcinoma |
0.035669932 |
Sensitive |
| ENSG00000225764.1 |
Motesanib |
Breast invasive carcinoma |
0.023489419 |
Sensitive |
| ENSG00000226471.2 |
Motesanib |
Breast invasive carcinoma |
0.023374437 |
Sensitive |
| ENSG00000228444.2 |
Motesanib |
Breast invasive carcinoma |
0.046109332 |
Sensitive |
| ENSG00000228554.1 |
Motesanib |
Breast invasive carcinoma |
0.004202676 |
Sensitive |
| ENSG00000228737.2 |
Motesanib |
Breast invasive carcinoma |
0.017823013 |
Sensitive |
| ENSG00000231187.2 |
Motesanib |
Breast invasive carcinoma |
0.00717129 |
Sensitive |
| ENSG00000231760.2 |
Motesanib |
Breast invasive carcinoma |
0.04530682 |
Sensitive |
| ENSG00000232046.2 |
Motesanib |
Breast invasive carcinoma |
0.003846311 |
Sensitive |
| ENSG00000232693.2 |
Motesanib |
Breast invasive carcinoma |
0.049602009 |
Sensitive |
| ENSG00000233478.1 |
Motesanib |
Breast invasive carcinoma |
0.02550612 |
Sensitive |
| ENSG00000233613.1 |
Motesanib |
Breast invasive carcinoma |
0.00671654 |
Sensitive |
| ENSG00000233621.1 |
Motesanib |
Breast invasive carcinoma |
0.034622899 |
Sensitive |
| ENSG00000233975.1 |
Motesanib |
Breast invasive carcinoma |
0.028333226 |
Sensitive |
| ENSG00000234478.1 |
Motesanib |
Breast invasive carcinoma |
0.027745199 |
Sensitive |
| ENSG00000234900.1 |
Motesanib |
Breast invasive carcinoma |
0.043429282 |
Sensitive |
| ENSG00000235271.1 |
Motesanib |
Breast invasive carcinoma |
0.013685559 |
Sensitive |
| ENSG00000236266.1 |
Motesanib |
Breast invasive carcinoma |
0.022979462 |
Sensitive |
| ENSG00000236546.1 |
Motesanib |
Breast invasive carcinoma |
0.028316002 |
Sensitive |
| ENSG00000240591.1 |
Motesanib |
Breast invasive carcinoma |
0.03218202 |
Sensitive |
| ENSG00000244625.1 |
Motesanib |
Breast invasive carcinoma |
0.045661471 |
Sensitive |
| ENSG00000247199.3 |
Motesanib |
Breast invasive carcinoma |
0.033214077 |
Sensitive |
| ENSG00000249532.2 |
Motesanib |
Breast invasive carcinoma |
0.023426041 |
Sensitive |
| ENSG00000250616.2 |
Motesanib |
Breast invasive carcinoma |
0.043104427 |
Sensitive |
| ENSG00000250635.1 |
Motesanib |
Breast invasive carcinoma |
0.025384055 |
Sensitive |
| ENSG00000251179.1 |
Motesanib |
Breast invasive carcinoma |
0.020863206 |
Sensitive |
| ENSG00000251330.3 |
Motesanib |
Breast invasive carcinoma |
0.003764345 |
Sensitive |
| ENSG00000254099.1 |
Motesanib |
Breast invasive carcinoma |
0.04431373 |
Sensitive |
| ENSG00000254606.1 |
Motesanib |
Breast invasive carcinoma |
0.021099412 |
Sensitive |
| ENSG00000257433.1 |
Motesanib |
Breast invasive carcinoma |
0.028889119 |
Sensitive |
| ENSG00000257809.1 |
Motesanib |
Breast invasive carcinoma |
0.045597647 |
Sensitive |
| ENSG00000259463.1 |
Motesanib |
Breast invasive carcinoma |
0.018732938 |
Sensitive |
| ENSG00000259933.2 |
Motesanib |
Breast invasive carcinoma |
0.003627617 |
Sensitive |
| ENSG00000259946.1 |
Motesanib |
Breast invasive carcinoma |
0.039925066 |
Sensitive |
| ENSG00000260038.1 |
Motesanib |
Breast invasive carcinoma |
0.018668125 |
Sensitive |
| ENSG00000260447.1 |
Motesanib |
Breast invasive carcinoma |
0.040020642 |
Sensitive |
| ENSG00000260592.1 |
Motesanib |
Breast invasive carcinoma |
0.018171028 |
Sensitive |
| ENSG00000260693.1 |
Motesanib |
Breast invasive carcinoma |
0.019133646 |
Sensitive |
| ENSG00000261064.1 |
Motesanib |
Breast invasive carcinoma |
0.022262178 |
Sensitive |
| ENSG00000261114.1 |
Motesanib |
Breast invasive carcinoma |
0.009976398 |
Sensitive |
| ENSG00000261123.1 |
Motesanib |
Breast invasive carcinoma |
0.005068901 |
Sensitive |
| ENSG00000261195.1 |
Motesanib |
Breast invasive carcinoma |
0.037483483 |
Sensitive |
| ENSG00000261270.1 |
Motesanib |
Breast invasive carcinoma |
0.009960327 |
Sensitive |
| ENSG00000261529.1 |
Motesanib |
Breast invasive carcinoma |
0.010532636 |
Sensitive |
| ENSG00000261888.1 |
Motesanib |
Breast invasive carcinoma |
0.046199348 |
Sensitive |
| ENSG00000262339.1 |
Motesanib |
Breast invasive carcinoma |
0.035346657 |
Sensitive |
| ENSG00000264964.1 |
Motesanib |
Breast invasive carcinoma |
0.015089972 |
Sensitive |
| ENSG00000267112.1 |
Motesanib |
Breast invasive carcinoma |
0.041750725 |
Sensitive |
| ENSG00000267117.1 |
Motesanib |
Breast invasive carcinoma |
0.020095617 |
Sensitive |
| ENSG00000267219.1 |
Motesanib |
Breast invasive carcinoma |
0.033082424 |
Sensitive |
| ENSG00000267658.1 |
Motesanib |
Breast invasive carcinoma |
0.029163727 |
Sensitive |
| ENSG00000236333.3 |
Motesanib |
Colon adenocarcinoma |
0.003809324 |
Sensitive |
| ENSG00000242258.1 |
Motesanib |
Colon adenocarcinoma |
0.023968735 |
Sensitive |
| ENSG00000242808.3 |
Motesanib |
Colon adenocarcinoma |
0.025683689 |
Sensitive |
| ENSG00000204625.6 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019216279 |
Sensitive |
| ENSG00000223697.2 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022272475 |
Sensitive |
| ENSG00000225506.2 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03186537 |
Sensitive |
| ENSG00000225798.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031002003 |
Sensitive |
| ENSG00000229990.2 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048042501 |
Sensitive |
| ENSG00000230925.3 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008330973 |
Sensitive |
| ENSG00000231742.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041277876 |
Sensitive |
| ENSG00000234230.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041393777 |
Sensitive |
| ENSG00000235236.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011357376 |
Sensitive |
| ENSG00000239828.2 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042318651 |
Sensitive |
| ENSG00000247372.2 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023285402 |
Sensitive |
| ENSG00000247950.2 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019227519 |
Sensitive |
| ENSG00000255320.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039013272 |
Sensitive |
| ENSG00000260411.2 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037862722 |
Sensitive |
| ENSG00000260591.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035134264 |
Sensitive |
| ENSG00000260841.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042505011 |
Sensitive |
| ENSG00000260936.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048359068 |
Sensitive |
| ENSG00000261286.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034952117 |
Sensitive |
| ENSG00000261372.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0100208 |
Sensitive |
| ENSG00000264304.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032719006 |
Sensitive |
| ENSG00000264608.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011273637 |
Sensitive |
| ENSG00000267658.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018631081 |
Sensitive |
| ENSG00000268945.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018375034 |
Sensitive |
| ENSG00000269925.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010609875 |
Sensitive |
| ENSG00000271732.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02151723 |
Sensitive |
| ENSG00000271843.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043015247 |
Sensitive |
| ENSG00000272156.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002105484 |
Sensitive |
| ENSG00000272263.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045430349 |
Sensitive |
| ENSG00000273183.1 |
Motesanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045367867 |
Sensitive |
| ENSG00000131484.3 |
Motesanib |
Esophageal cancer |
0.005880568 |
Sensitive |
| ENSG00000167912.5 |
Motesanib |
Esophageal cancer |
0.01767946 |
Sensitive |
| ENSG00000179743.2 |
Motesanib |
Esophageal cancer |
0.008875536 |
Sensitive |
| ENSG00000181097.5 |
Motesanib |
Esophageal cancer |
0.017444988 |
Sensitive |
| ENSG00000182873.4 |
Motesanib |
Esophageal cancer |
0.010268559 |
Sensitive |
| ENSG00000185837.3 |
Motesanib |
Esophageal cancer |
0.001053273 |
Sensitive |
| ENSG00000188365.3 |
Motesanib |
Esophageal cancer |
0.035072579 |
Sensitive |
| ENSG00000196295.7 |
Motesanib |
Esophageal cancer |
0.002300053 |
Sensitive |
| ENSG00000196421.3 |
Motesanib |
Esophageal cancer |
0.000572816 |
Sensitive |
| ENSG00000203497.2 |
Motesanib |
Esophageal cancer |
0.017045315 |
Sensitive |
| ENSG00000205041.1 |
Motesanib |
Esophageal cancer |
0.000645882 |
Sensitive |
| ENSG00000205266.5 |
Motesanib |
Esophageal cancer |
0.035268717 |
Sensitive |
| ENSG00000205959.3 |
Motesanib |
Esophageal cancer |
0.012416506 |
Sensitive |
| ENSG00000211683.3 |
Motesanib |
Esophageal cancer |
0.000309285 |
Sensitive |
| ENSG00000212694.4 |
Motesanib |
Esophageal cancer |
0.049923372 |
Sensitive |
| ENSG00000213994.3 |
Motesanib |
Esophageal cancer |
0.020836757 |
Sensitive |
| ENSG00000218510.3 |
Motesanib |
Esophageal cancer |
0.008474971 |
Sensitive |
| ENSG00000223579.2 |
Motesanib |
Esophageal cancer |
0.011626586 |
Sensitive |
| ENSG00000223704.1 |
Motesanib |
Esophageal cancer |
0.01690053 |
Sensitive |
| ENSG00000223745.3 |
Motesanib |
Esophageal cancer |
0.022112259 |
Sensitive |
| ENSG00000223774.1 |
Motesanib |
Esophageal cancer |
0.047429483 |
Sensitive |
| ENSG00000223842.1 |
Motesanib |
Esophageal cancer |
0.028704942 |
Sensitive |
| ENSG00000224079.1 |
Motesanib |
Esophageal cancer |
0.00132301 |
Sensitive |
| ENSG00000224100.1 |
Motesanib |
Esophageal cancer |
0.026992199 |
Sensitive |
| ENSG00000224441.1 |
Motesanib |
Esophageal cancer |
0.019905443 |
Sensitive |
| ENSG00000224899.1 |
Motesanib |
Esophageal cancer |
0.008688857 |
Sensitive |
| ENSG00000224945.1 |
Motesanib |
Esophageal cancer |
0.047019724 |
Sensitive |
| ENSG00000224972.1 |
Motesanib |
Esophageal cancer |
0.037862335 |
Sensitive |
| ENSG00000225300.1 |
Motesanib |
Esophageal cancer |
0.006190472 |
Sensitive |
| ENSG00000225353.2 |
Motesanib |
Esophageal cancer |
0.048914763 |
Sensitive |
| ENSG00000225578.1 |
Motesanib |
Esophageal cancer |
0.010535742 |
Sensitive |
| ENSG00000225975.2 |
Motesanib |
Esophageal cancer |
0.00108663 |
Sensitive |
| ENSG00000225981.1 |
Motesanib |
Esophageal cancer |
0.01066816 |
Sensitive |
| ENSG00000226009.1 |
Motesanib |
Esophageal cancer |
0.020585318 |
Sensitive |
| ENSG00000226029.1 |
Motesanib |
Esophageal cancer |
0.039040237 |
Sensitive |
| ENSG00000226696.1 |
Motesanib |
Esophageal cancer |
0.045954723 |
Sensitive |
| ENSG00000226904.1 |
Motesanib |
Esophageal cancer |
0.030413888 |
Sensitive |
| ENSG00000227110.2 |
Motesanib |
Esophageal cancer |
0.015860084 |
Sensitive |
| ENSG00000227256.1 |
Motesanib |
Esophageal cancer |
0.006995335 |
Sensitive |
| ENSG00000227279.1 |
Motesanib |
Esophageal cancer |
0.006393301 |
Sensitive |
| ENSG00000227479.1 |
Motesanib |
Esophageal cancer |
0.015804996 |
Sensitive |
| ENSG00000227492.1 |
Motesanib |
Esophageal cancer |
0.02199405 |
Sensitive |
| ENSG00000227603.1 |
Motesanib |
Esophageal cancer |
0.03516477 |
Sensitive |
| ENSG00000227606.2 |
Motesanib |
Esophageal cancer |
0.013691286 |
Sensitive |
| ENSG00000228084.1 |
Motesanib |
Esophageal cancer |
0.009867453 |
Sensitive |
| ENSG00000228315.7 |
Motesanib |
Esophageal cancer |
0.011633198 |
Sensitive |
| ENSG00000228393.3 |
Motesanib |
Esophageal cancer |
0.032152426 |
Sensitive |
| ENSG00000228544.1 |
Motesanib |
Esophageal cancer |
0.044432514 |
Sensitive |
| ENSG00000228661.1 |
Motesanib |
Esophageal cancer |
0.03365579 |
Sensitive |
| ENSG00000228677.1 |
Motesanib |
Esophageal cancer |
0.030558195 |
Sensitive |
| ENSG00000228701.1 |
Motesanib |
Esophageal cancer |
0.022808795 |
Sensitive |
| ENSG00000228734.2 |
Motesanib |
Esophageal cancer |
0.047082156 |
Sensitive |
| ENSG00000228802.1 |
Motesanib |
Esophageal cancer |
0.033857678 |
Sensitive |
| ENSG00000229180.4 |
Motesanib |
Esophageal cancer |
0.005513138 |
Sensitive |
| ENSG00000229463.2 |
Motesanib |
Esophageal cancer |
0.001181477 |
Sensitive |
| ENSG00000230310.1 |
Motesanib |
Esophageal cancer |
0.006245358 |
Sensitive |
| ENSG00000230415.1 |
Motesanib |
Esophageal cancer |
0.028857035 |
Sensitive |
| ENSG00000230424.1 |
Motesanib |
Esophageal cancer |
0.012771023 |
Sensitive |
| ENSG00000230612.1 |
Motesanib |
Esophageal cancer |
0.042031449 |
Sensitive |
| ENSG00000230613.1 |
Motesanib |
Esophageal cancer |
0.001857352 |
Sensitive |
| ENSG00000231113.2 |
Motesanib |
Esophageal cancer |
0.006456188 |
Sensitive |
| ENSG00000231154.1 |
Motesanib |
Esophageal cancer |
0.031144375 |
Sensitive |
| ENSG00000231249.1 |
Motesanib |
Esophageal cancer |
0.008062492 |
Sensitive |
| ENSG00000231611.1 |
Motesanib |
Esophageal cancer |
0.031787623 |
Sensitive |
| ENSG00000231646.1 |
Motesanib |
Esophageal cancer |
0.037383344 |
Sensitive |
| ENSG00000231764.4 |
Motesanib |
Esophageal cancer |
0.001724145 |
Sensitive |
| ENSG00000231871.1 |
Motesanib |
Esophageal cancer |
0.014842264 |
Sensitive |
| ENSG00000231889.3 |
Motesanib |
Esophageal cancer |
0.005733685 |
Sensitive |
| ENSG00000231999.2 |
Motesanib |
Esophageal cancer |
0.049526279 |
Sensitive |
| ENSG00000232098.2 |
Motesanib |
Esophageal cancer |
0.049350808 |
Sensitive |
| ENSG00000232274.2 |
Motesanib |
Esophageal cancer |
0.043032949 |
Sensitive |
| ENSG00000232284.3 |
Motesanib |
Esophageal cancer |
0.002059525 |
Sensitive |
| ENSG00000232336.1 |
Motesanib |
Esophageal cancer |
0.001061713 |
Sensitive |
| ENSG00000232586.1 |
Motesanib |
Esophageal cancer |
0.007313445 |
Sensitive |
| ENSG00000232611.1 |
Motesanib |
Esophageal cancer |
0.017626511 |
Sensitive |
| ENSG00000232633.3 |
Motesanib |
Esophageal cancer |
0.011266219 |
Sensitive |
| ENSG00000232732.5 |
Motesanib |
Esophageal cancer |
0.016322318 |
Sensitive |
| ENSG00000232893.1 |
Motesanib |
Esophageal cancer |
0.002849525 |
Sensitive |
| ENSG00000233452.2 |
Motesanib |
Esophageal cancer |
0.004107323 |
Sensitive |
| ENSG00000233783.3 |
Motesanib |
Esophageal cancer |
0.04066267 |
Sensitive |
| ENSG00000234134.1 |
Motesanib |
Esophageal cancer |
0.002510379 |
Sensitive |
| ENSG00000234160.1 |
Motesanib |
Esophageal cancer |
0.038570228 |
Sensitive |
| ENSG00000234206.1 |
Motesanib |
Esophageal cancer |
0.017017986 |
Sensitive |
| ENSG00000234264.1 |
Motesanib |
Esophageal cancer |
0.036014134 |
Sensitive |
| ENSG00000234617.1 |
Motesanib |
Esophageal cancer |
0.001243783 |
Sensitive |
| ENSG00000234676.1 |
Motesanib |
Esophageal cancer |
0.001660283 |
Sensitive |
| ENSG00000234694.1 |
Motesanib |
Esophageal cancer |
0.039396473 |
Sensitive |
| ENSG00000234763.1 |
Motesanib |
Esophageal cancer |
0.035991196 |
Sensitive |
| ENSG00000234936.1 |
Motesanib |
Esophageal cancer |
0.01696367 |
Sensitive |
| ENSG00000235052.1 |
Motesanib |
Esophageal cancer |
0.000959362 |
Sensitive |
| ENSG00000235092.1 |
Motesanib |
Esophageal cancer |
0.044056257 |
Sensitive |
| ENSG00000235706.3 |
Motesanib |
Esophageal cancer |
0.020236586 |
Sensitive |
| ENSG00000235770.1 |
Motesanib |
Esophageal cancer |
0.011539963 |
Sensitive |
| ENSG00000236144.2 |
Motesanib |
Esophageal cancer |
0.0000932 |
Sensitive |
| ENSG00000236463.1 |
Motesanib |
Esophageal cancer |
0.009070409 |
Sensitive |
| ENSG00000236643.1 |
Motesanib |
Esophageal cancer |
0.027141264 |
Sensitive |
| ENSG00000236711.2 |
Motesanib |
Esophageal cancer |
0.01206203 |
Sensitive |
| ENSG00000236810.1 |
Motesanib |
Esophageal cancer |
0.039002698 |
Sensitive |
| ENSG00000236859.2 |
Motesanib |
Esophageal cancer |
0.005967921 |
Sensitive |
| ENSG00000236896.1 |
Motesanib |
Esophageal cancer |
0.028079525 |
Sensitive |
| ENSG00000236901.3 |
Motesanib |
Esophageal cancer |
0.009233885 |
Sensitive |
| ENSG00000237128.1 |
Motesanib |
Esophageal cancer |
0.04955099 |
Sensitive |
| ENSG00000237489.2 |
Motesanib |
Esophageal cancer |
0.000417077 |
Sensitive |
| ENSG00000237491.4 |
Motesanib |
Esophageal cancer |
0.03878626 |
Sensitive |
| ENSG00000237836.1 |
Motesanib |
Esophageal cancer |
0.011633775 |
Sensitive |
| ENSG00000239911.1 |
Motesanib |
Esophageal cancer |
0.010561281 |
Sensitive |
| ENSG00000240453.1 |
Motesanib |
Esophageal cancer |
0.022353586 |
Sensitive |
| ENSG00000240758.2 |
Motesanib |
Esophageal cancer |
0.0028896 |
Sensitive |
| ENSG00000240990.5 |
Motesanib |
Esophageal cancer |
0.012429897 |
Sensitive |
| ENSG00000242474.1 |
Motesanib |
Esophageal cancer |
0.013276927 |
Sensitive |
| ENSG00000242578.1 |
Motesanib |
Esophageal cancer |
0.046932177 |
Sensitive |
| ENSG00000243230.1 |
Motesanib |
Esophageal cancer |
0.01942715 |
Sensitive |
| ENSG00000244757.1 |
Motesanib |
Esophageal cancer |
0.016703575 |
Sensitive |
| ENSG00000245322.2 |
Motesanib |
Esophageal cancer |
0.00212538 |
Sensitive |
| ENSG00000245556.2 |
Motesanib |
Esophageal cancer |
0.031759494 |
Sensitive |
| ENSG00000246174.3 |
Motesanib |
Esophageal cancer |
0.001072306 |
Sensitive |
| ENSG00000246528.3 |
Motesanib |
Esophageal cancer |
0.025979294 |
Sensitive |
| ENSG00000246560.2 |
Motesanib |
Esophageal cancer |
0.029989545 |
Sensitive |
| ENSG00000246763.2 |
Motesanib |
Esophageal cancer |
0.026997039 |
Sensitive |
| ENSG00000246792.2 |
Motesanib |
Esophageal cancer |
0.004577564 |
Sensitive |
| ENSG00000246982.2 |
Motesanib |
Esophageal cancer |
0.00000542 |
Sensitive |
| ENSG00000247400.3 |
Motesanib |
Esophageal cancer |
0.023507655 |
Sensitive |
| ENSG00000247679.2 |
Motesanib |
Esophageal cancer |
0.042704842 |
Sensitive |
| ENSG00000247708.3 |
Motesanib |
Esophageal cancer |
0.014924327 |
Sensitive |
| ENSG00000248206.1 |
Motesanib |
Esophageal cancer |
0.025085442 |
Sensitive |
| ENSG00000248309.1 |
Motesanib |
Esophageal cancer |
0.041219258 |
Sensitive |
| ENSG00000248373.1 |
Motesanib |
Esophageal cancer |
0.001500185 |
Sensitive |
| ENSG00000248559.1 |
Motesanib |
Esophageal cancer |
0.023824057 |
Sensitive |
| ENSG00000249096.2 |
Motesanib |
Esophageal cancer |
0.017472524 |
Sensitive |
| ENSG00000249456.1 |
Motesanib |
Esophageal cancer |
0.008543739 |
Sensitive |
| ENSG00000249476.1 |
Motesanib |
Esophageal cancer |
0.016162503 |
Sensitive |
| ENSG00000249641.2 |
Motesanib |
Esophageal cancer |
0.005022888 |
Sensitive |
| ENSG00000249846.2 |
Motesanib |
Esophageal cancer |
0.018115193 |
Sensitive |
| ENSG00000249916.1 |
Motesanib |
Esophageal cancer |
0.014865742 |
Sensitive |
| ENSG00000250220.1 |
Motesanib |
Esophageal cancer |
0.003179788 |
Sensitive |
| ENSG00000250917.1 |
Motesanib |
Esophageal cancer |
0.005493594 |
Sensitive |
| ENSG00000250988.3 |
Motesanib |
Esophageal cancer |
0.020598973 |
Sensitive |
| ENSG00000251009.2 |
Motesanib |
Esophageal cancer |
0.000713884 |
Sensitive |
| ENSG00000251292.1 |
Motesanib |
Esophageal cancer |
0.010426755 |
Sensitive |
| ENSG00000251556.1 |
Motesanib |
Esophageal cancer |
0.008208857 |
Sensitive |
| ENSG00000251602.2 |
Motesanib |
Esophageal cancer |
0.042192729 |
Sensitive |
| ENSG00000251615.3 |
Motesanib |
Esophageal cancer |
0.041407185 |
Sensitive |
| ENSG00000251661.3 |
Motesanib |
Esophageal cancer |
0.0000152 |
Sensitive |
| ENSG00000251687.1 |
Motesanib |
Esophageal cancer |
0.033011819 |
Sensitive |
| ENSG00000253141.1 |
Motesanib |
Esophageal cancer |
0.005835328 |
Sensitive |
| ENSG00000253347.1 |
Motesanib |
Esophageal cancer |
0.036328957 |
Sensitive |
| ENSG00000253433.1 |
Motesanib |
Esophageal cancer |
0.013707746 |
Sensitive |
| ENSG00000253507.1 |
Motesanib |
Esophageal cancer |
0.007627543 |
Sensitive |
| ENSG00000253508.1 |
Motesanib |
Esophageal cancer |
0.022083986 |
Sensitive |
| ENSG00000253716.1 |
Motesanib |
Esophageal cancer |
0.012354863 |
Sensitive |
| ENSG00000253773.1 |
Motesanib |
Esophageal cancer |
0.047640449 |
Sensitive |
| ENSG00000253878.1 |
Motesanib |
Esophageal cancer |
0.039007267 |
Sensitive |
| ENSG00000253948.1 |
Motesanib |
Esophageal cancer |
0.000612764 |
Sensitive |
| ENSG00000254042.1 |
Motesanib |
Esophageal cancer |
0.027627634 |
Sensitive |
| ENSG00000254187.1 |
Motesanib |
Esophageal cancer |
0.000293911 |
Sensitive |
| ENSG00000254837.1 |
Motesanib |
Esophageal cancer |
0.037349706 |
Sensitive |
| ENSG00000254981.1 |
Motesanib |
Esophageal cancer |
0.03655442 |
Sensitive |
| ENSG00000254990.1 |
Motesanib |
Esophageal cancer |
0.000445983 |
Sensitive |
| ENSG00000255142.1 |
Motesanib |
Esophageal cancer |
0.006992348 |
Sensitive |
| ENSG00000255158.1 |
Motesanib |
Esophageal cancer |
0.041837111 |
Sensitive |
| ENSG00000255234.1 |
Motesanib |
Esophageal cancer |
0.008224639 |
Sensitive |
| ENSG00000255318.1 |
Motesanib |
Esophageal cancer |
0.045383447 |
Sensitive |
| ENSG00000255669.1 |
Motesanib |
Esophageal cancer |
0.006341757 |
Sensitive |
| ENSG00000255741.1 |
Motesanib |
Esophageal cancer |
0.013567484 |
Sensitive |
| ENSG00000255847.1 |
Motesanib |
Esophageal cancer |
0.011685316 |
Sensitive |
| ENSG00000255966.1 |
Motesanib |
Esophageal cancer |
0.011912058 |
Sensitive |
| ENSG00000256011.1 |
Motesanib |
Esophageal cancer |
0.007623898 |
Sensitive |
| ENSG00000257221.1 |
Motesanib |
Esophageal cancer |
0.040795015 |
Sensitive |
| ENSG00000257283.1 |
Motesanib |
Esophageal cancer |
0.044823778 |
Sensitive |
| ENSG00000257449.1 |
Motesanib |
Esophageal cancer |
0.006804424 |
Sensitive |
| ENSG00000257809.1 |
Motesanib |
Esophageal cancer |
0.003699397 |
Sensitive |
| ENSG00000258086.1 |
Motesanib |
Esophageal cancer |
0.006641489 |
Sensitive |
| ENSG00000258101.1 |
Motesanib |
Esophageal cancer |
0.02073562 |
Sensitive |
| ENSG00000258136.1 |
Motesanib |
Esophageal cancer |
0.043584772 |
Sensitive |
| ENSG00000258302.1 |
Motesanib |
Esophageal cancer |
0.035118213 |
Sensitive |
| ENSG00000258317.1 |
Motesanib |
Esophageal cancer |
0.044426503 |
Sensitive |
| ENSG00000258428.1 |
Motesanib |
Esophageal cancer |
0.018323626 |
Sensitive |
| ENSG00000258450.1 |
Motesanib |
Esophageal cancer |
0.04875864 |
Sensitive |
| ENSG00000258809.1 |
Motesanib |
Esophageal cancer |
0.035441321 |
Sensitive |
| ENSG00000258938.1 |
Motesanib |
Esophageal cancer |
0.031350739 |
Sensitive |
| ENSG00000258957.1 |
Motesanib |
Esophageal cancer |
0.007817195 |
Sensitive |
| ENSG00000259001.2 |
Motesanib |
Esophageal cancer |
0.000904628 |
Sensitive |
| ENSG00000259081.1 |
Motesanib |
Esophageal cancer |
0.018311413 |
Sensitive |
| ENSG00000259551.1 |
Motesanib |
Esophageal cancer |
0.001270633 |
Sensitive |
| ENSG00000259673.1 |
Motesanib |
Esophageal cancer |
0.030428559 |
Sensitive |
| ENSG00000259714.1 |
Motesanib |
Esophageal cancer |
0.036171254 |
Sensitive |
| ENSG00000259775.1 |
Motesanib |
Esophageal cancer |
0.043969959 |
Sensitive |
| ENSG00000259783.1 |
Motesanib |
Esophageal cancer |
0.001250833 |
Sensitive |
| ENSG00000259806.2 |
Motesanib |
Esophageal cancer |
0.0222734 |
Sensitive |
| ENSG00000259891.1 |
Motesanib |
Esophageal cancer |
0.015841872 |
Sensitive |
| ENSG00000259943.1 |
Motesanib |
Esophageal cancer |
0.016405842 |
Sensitive |
| ENSG00000259994.1 |
Motesanib |
Esophageal cancer |
0.039046101 |
Sensitive |
| ENSG00000260083.1 |
Motesanib |
Esophageal cancer |
0.015765883 |
Sensitive |
| ENSG00000260100.1 |
Motesanib |
Esophageal cancer |
0.009982473 |
Sensitive |
| ENSG00000260177.1 |
Motesanib |
Esophageal cancer |
0.014862056 |
Sensitive |
| ENSG00000260276.1 |
Motesanib |
Esophageal cancer |
0.034430653 |
Sensitive |
| ENSG00000260278.1 |
Motesanib |
Esophageal cancer |
0.012732322 |
Sensitive |
| ENSG00000260331.1 |
Motesanib |
Esophageal cancer |
0.045078561 |
Sensitive |
| ENSG00000260361.1 |
Motesanib |
Esophageal cancer |
0.000549902 |
Sensitive |
| ENSG00000260372.2 |
Motesanib |
Esophageal cancer |
0.036869993 |
Sensitive |
| ENSG00000260411.2 |
Motesanib |
Esophageal cancer |
0.03928384 |
Sensitive |
| ENSG00000260475.1 |
Motesanib |
Esophageal cancer |
0.019024675 |
Sensitive |
| ENSG00000260625.1 |
Motesanib |
Esophageal cancer |
0.0457199 |
Sensitive |
| ENSG00000260643.1 |
Motesanib |
Esophageal cancer |
0.04122566 |
Sensitive |
| ENSG00000260647.1 |
Motesanib |
Esophageal cancer |
0.016450858 |
Sensitive |
| ENSG00000260693.1 |
Motesanib |
Esophageal cancer |
0.020725213 |
Sensitive |
| ENSG00000260793.2 |
Motesanib |
Esophageal cancer |
0.000848752 |
Sensitive |
| ENSG00000260976.1 |
Motesanib |
Esophageal cancer |
0.00278687 |
Sensitive |
| ENSG00000260978.1 |
Motesanib |
Esophageal cancer |
0.044777847 |
Sensitive |
| ENSG00000261064.1 |
Motesanib |
Esophageal cancer |
0.019675656 |
Sensitive |
| ENSG00000261251.1 |
Motesanib |
Esophageal cancer |
0.014941606 |
Sensitive |
| ENSG00000261252.1 |
Motesanib |
Esophageal cancer |
0.008513147 |
Sensitive |
| ENSG00000261360.1 |
Motesanib |
Esophageal cancer |
0.034138298 |
Sensitive |
| ENSG00000261481.1 |
Motesanib |
Esophageal cancer |
0.021330771 |
Sensitive |
| ENSG00000261595.1 |
Motesanib |
Esophageal cancer |
0.005747033 |
Sensitive |
| ENSG00000261766.1 |
Motesanib |
Esophageal cancer |
0.030275634 |
Sensitive |
| ENSG00000261799.1 |
Motesanib |
Esophageal cancer |
0.007819492 |
Sensitive |
| ENSG00000261879.1 |
Motesanib |
Esophageal cancer |
0.012482706 |
Sensitive |
| ENSG00000261971.2 |
Motesanib |
Esophageal cancer |
0.0498844 |
Sensitive |
| ENSG00000262194.1 |
Motesanib |
Esophageal cancer |
0.023330537 |
Sensitive |
| ENSG00000262228.1 |
Motesanib |
Esophageal cancer |
0.004640794 |
Sensitive |
| ENSG00000263033.1 |
Motesanib |
Esophageal cancer |
0.006778089 |
Sensitive |
| ENSG00000263916.1 |
Motesanib |
Esophageal cancer |
0.005683906 |
Sensitive |
| ENSG00000264247.1 |
Motesanib |
Esophageal cancer |
0.026672568 |
Sensitive |
| ENSG00000265394.1 |
Motesanib |
Esophageal cancer |
0.002359735 |
Sensitive |
| ENSG00000265479.1 |
Motesanib |
Esophageal cancer |
0.041925321 |
Sensitive |
| ENSG00000266261.1 |
Motesanib |
Esophageal cancer |
0.000172104 |
Sensitive |
| ENSG00000267034.1 |
Motesanib |
Esophageal cancer |
0.001954012 |
Sensitive |
| ENSG00000267067.1 |
Motesanib |
Esophageal cancer |
0.047102217 |
Sensitive |
| ENSG00000267080.1 |
Motesanib |
Esophageal cancer |
0.009913541 |
Sensitive |
| ENSG00000267130.1 |
Motesanib |
Esophageal cancer |
0.019507822 |
Sensitive |
| ENSG00000267167.1 |
Motesanib |
Esophageal cancer |
0.020948759 |
Sensitive |
| ENSG00000267174.1 |
Motesanib |
Esophageal cancer |
0.030417424 |
Sensitive |
| ENSG00000267277.1 |
Motesanib |
Esophageal cancer |
0.020578942 |
Sensitive |
| ENSG00000267285.1 |
Motesanib |
Esophageal cancer |
0.039874543 |
Sensitive |
| ENSG00000267390.1 |
Motesanib |
Esophageal cancer |
0.039520208 |
Sensitive |
| ENSG00000267395.1 |
Motesanib |
Esophageal cancer |
0.020350133 |
Sensitive |
| ENSG00000267546.2 |
Motesanib |
Esophageal cancer |
0.001190577 |
Sensitive |
| ENSG00000267730.1 |
Motesanib |
Esophageal cancer |
0.012432951 |
Sensitive |
| ENSG00000267852.1 |
Motesanib |
Esophageal cancer |
0.014599914 |
Sensitive |
| ENSG00000267904.1 |
Motesanib |
Esophageal cancer |
0.004892739 |
Sensitive |
| ENSG00000267939.1 |
Motesanib |
Esophageal cancer |
0.02137814 |
Sensitive |
| ENSG00000268049.1 |
Motesanib |
Esophageal cancer |
0.001192151 |
Sensitive |
| ENSG00000268087.1 |
Motesanib |
Esophageal cancer |
0.004258425 |
Sensitive |
| ENSG00000268205.1 |
Motesanib |
Esophageal cancer |
0.04990329 |
Sensitive |
| ENSG00000268518.1 |
Motesanib |
Esophageal cancer |
0.048804225 |
Sensitive |
| ENSG00000268564.1 |
Motesanib |
Esophageal cancer |
0.021825518 |
Sensitive |
| ENSG00000268751.1 |
Motesanib |
Esophageal cancer |
0.046501602 |
Sensitive |
| ENSG00000268945.1 |
Motesanib |
Esophageal cancer |
0.035784533 |
Sensitive |
| ENSG00000269038.1 |
Motesanib |
Esophageal cancer |
0.038930162 |
Sensitive |
| ENSG00000269044.1 |
Motesanib |
Esophageal cancer |
0.003121433 |
Sensitive |
| ENSG00000269202.1 |
Motesanib |
Esophageal cancer |
0.03028884 |
Sensitive |
| ENSG00000269293.2 |
Motesanib |
Esophageal cancer |
0.006624489 |
Sensitive |
| ENSG00000269386.1 |
Motesanib |
Esophageal cancer |
0.025372711 |
Sensitive |
| ENSG00000269400.1 |
Motesanib |
Esophageal cancer |
0.04058416 |
Sensitive |
| ENSG00000269427.1 |
Motesanib |
Esophageal cancer |
0.001634763 |
Sensitive |
| ENSG00000269694.1 |
Motesanib |
Esophageal cancer |
0.002132046 |
Sensitive |
| ENSG00000269892.1 |
Motesanib |
Esophageal cancer |
0.048905164 |
Sensitive |
| ENSG00000269896.1 |
Motesanib |
Esophageal cancer |
0.027871846 |
Sensitive |
| ENSG00000269903.1 |
Motesanib |
Esophageal cancer |
0.0000417 |
Sensitive |
| ENSG00000269947.1 |
Motesanib |
Esophageal cancer |
0.005040277 |
Sensitive |
| ENSG00000269959.1 |
Motesanib |
Esophageal cancer |
0.044820347 |
Sensitive |
| ENSG00000270006.1 |
Motesanib |
Esophageal cancer |
0.025238644 |
Sensitive |
| ENSG00000270019.1 |
Motesanib |
Esophageal cancer |
0.012117592 |
Sensitive |
| ENSG00000270030.1 |
Motesanib |
Esophageal cancer |
0.004685511 |
Sensitive |
| ENSG00000270039.1 |
Motesanib |
Esophageal cancer |
0.006082775 |
Sensitive |
| ENSG00000270041.1 |
Motesanib |
Esophageal cancer |
0.014047659 |
Sensitive |
| ENSG00000270049.1 |
Motesanib |
Esophageal cancer |
0.04134367 |
Sensitive |
| ENSG00000270052.1 |
Motesanib |
Esophageal cancer |
0.018095661 |
Sensitive |
| ENSG00000270062.1 |
Motesanib |
Esophageal cancer |
0.003070858 |
Sensitive |
| ENSG00000270105.1 |
Motesanib |
Esophageal cancer |
0.022664037 |
Sensitive |
| ENSG00000270143.1 |
Motesanib |
Esophageal cancer |
0.037174795 |
Sensitive |
| ENSG00000271032.1 |
Motesanib |
Esophageal cancer |
0.047247544 |
Sensitive |
| ENSG00000271265.1 |
Motesanib |
Esophageal cancer |
0.000100951 |
Sensitive |
| ENSG00000271789.1 |
Motesanib |
Esophageal cancer |
0.012212362 |
Sensitive |
| ENSG00000271843.1 |
Motesanib |
Esophageal cancer |
0.001771436 |
Sensitive |
| ENSG00000271851.1 |
Motesanib |
Esophageal cancer |
0.007883797 |
Sensitive |
| ENSG00000272048.1 |
Motesanib |
Esophageal cancer |
0.000601715 |
Sensitive |
| ENSG00000272077.1 |
Motesanib |
Esophageal cancer |
0.016211199 |
Sensitive |
| ENSG00000272142.1 |
Motesanib |
Esophageal cancer |
0.040709354 |
Sensitive |
| ENSG00000272148.1 |
Motesanib |
Esophageal cancer |
0.021731837 |
Sensitive |
| ENSG00000272361.1 |
Motesanib |
Esophageal cancer |
0.016596309 |
Sensitive |
| ENSG00000272374.1 |
Motesanib |
Esophageal cancer |
0.019464226 |
Sensitive |
| ENSG00000272386.1 |
Motesanib |
Esophageal cancer |
0.000385097 |
Sensitive |
| ENSG00000272389.1 |
Motesanib |
Esophageal cancer |
0.016676804 |
Sensitive |
| ENSG00000272402.1 |
Motesanib |
Esophageal cancer |
0.003505884 |
Sensitive |
| ENSG00000272457.1 |
Motesanib |
Esophageal cancer |
0.013746577 |
Sensitive |
| ENSG00000272660.1 |
Motesanib |
Esophageal cancer |
0.033035368 |
Sensitive |
| ENSG00000272764.1 |
Motesanib |
Esophageal cancer |
0.037705209 |
Sensitive |
| ENSG00000272791.1 |
Motesanib |
Esophageal cancer |
0.006298469 |
Sensitive |
| ENSG00000272828.1 |
Motesanib |
Esophageal cancer |
0.038898863 |
Sensitive |
| ENSG00000272849.1 |
Motesanib |
Esophageal cancer |
0.010444351 |
Sensitive |
| ENSG00000272864.1 |
Motesanib |
Esophageal cancer |
0.029862786 |
Sensitive |
| ENSG00000273000.1 |
Motesanib |
Esophageal cancer |
0.020624052 |
Sensitive |
| ENSG00000273032.1 |
Motesanib |
Esophageal cancer |
0.026237835 |
Sensitive |
| ENSG00000273218.1 |
Motesanib |
Esophageal cancer |
0.010282506 |
Sensitive |
| ENSG00000273233.1 |
Motesanib |
Esophageal cancer |
0.002607753 |
Sensitive |
| ENSG00000273249.1 |
Motesanib |
Esophageal cancer |
0.0000524 |
Sensitive |
| ENSG00000273257.1 |
Motesanib |
Esophageal cancer |
0.01163009 |
Sensitive |
| ENSG00000273289.1 |
Motesanib |
Esophageal cancer |
0.01298327 |
Sensitive |
| ENSG00000273308.1 |
Motesanib |
Esophageal cancer |
0.038842805 |
Sensitive |
| ENSG00000273344.1 |
Motesanib |
Esophageal cancer |
0.019963872 |
Sensitive |
| ENSG00000273437.1 |
Motesanib |
Esophageal cancer |
0.016573996 |
Sensitive |
| ENSG00000273454.1 |
Motesanib |
Esophageal cancer |
0.049813998 |
Sensitive |
| ENSG00000273473.1 |
Motesanib |
Esophageal cancer |
0.032944024 |
Sensitive |
| ENSG00000273481.1 |
Motesanib |
Esophageal cancer |
0.000542771 |
Sensitive |
| ENSG00000215190.4 |
Motesanib |
Brain lower grade glioma |
0.03592799 |
Sensitive |
| ENSG00000223734.2 |
Motesanib |
Brain lower grade glioma |
0.02425768 |
Sensitive |
| ENSG00000225407.3 |
Motesanib |
Brain lower grade glioma |
0.028631218 |
Sensitive |
| ENSG00000226876.2 |
Motesanib |
Brain lower grade glioma |
0.042296814 |
Sensitive |
| ENSG00000233086.3 |
Motesanib |
Brain lower grade glioma |
0.022904837 |
Sensitive |
| ENSG00000236463.1 |
Motesanib |
Brain lower grade glioma |
0.017933896 |
Sensitive |
| ENSG00000236494.1 |
Motesanib |
Brain lower grade glioma |
0.043312112 |
Sensitive |
| ENSG00000238078.1 |
Motesanib |
Brain lower grade glioma |
0.028107188 |
Sensitive |
| ENSG00000242136.1 |
Motesanib |
Brain lower grade glioma |
0.03389126 |
Sensitive |
| ENSG00000246090.2 |
Motesanib |
Brain lower grade glioma |
0.030493845 |
Sensitive |
| ENSG00000247324.2 |
Motesanib |
Brain lower grade glioma |
0.031266801 |
Sensitive |
| ENSG00000247372.2 |
Motesanib |
Brain lower grade glioma |
0.035790076 |
Sensitive |
| ENSG00000248476.1 |
Motesanib |
Brain lower grade glioma |
0.029571975 |
Sensitive |
| ENSG00000250132.2 |
Motesanib |
Brain lower grade glioma |
0.037232603 |
Sensitive |
| ENSG00000251613.3 |
Motesanib |
Brain lower grade glioma |
0.025882468 |
Sensitive |
| ENSG00000254539.1 |
Motesanib |
Brain lower grade glioma |
0.031111905 |
Sensitive |
| ENSG00000254691.1 |
Motesanib |
Brain lower grade glioma |
0.0455345 |
Sensitive |
| ENSG00000257023.1 |
Motesanib |
Brain lower grade glioma |
0.025978312 |
Sensitive |
| ENSG00000257613.1 |
Motesanib |
Brain lower grade glioma |
0.02709513 |
Sensitive |
| ENSG00000260744.1 |
Motesanib |
Brain lower grade glioma |
0.01639327 |
Sensitive |
| ENSG00000261280.2 |
Motesanib |
Brain lower grade glioma |
0.049117996 |
Sensitive |
| ENSG00000261404.1 |
Motesanib |
Brain lower grade glioma |
0.04166266 |
Sensitive |
| ENSG00000263603.1 |
Motesanib |
Brain lower grade glioma |
0.031158835 |
Sensitive |
| ENSG00000264940.2 |
Motesanib |
Brain lower grade glioma |
0.018380199 |
Sensitive |
| ENSG00000267886.1 |
Motesanib |
Brain lower grade glioma |
0.049579223 |
Sensitive |
| ENSG00000268362.1 |
Motesanib |
Brain lower grade glioma |
0.033881745 |
Sensitive |
| ENSG00000271228.1 |
Motesanib |
Brain lower grade glioma |
0.032409548 |
Sensitive |
| ENSG00000272308.1 |
Motesanib |
Brain lower grade glioma |
0.032986852 |
Sensitive |
| ENSG00000272417.1 |
Motesanib |
Brain lower grade glioma |
0.048698102 |
Sensitive |
| ENSG00000272862.1 |
Motesanib |
Brain lower grade glioma |
0.044509101 |
Sensitive |
| ENSG00000088970.11 |
Motesanib |
Liver hepatocellular carcinoma |
0.03255628 |
Sensitive |
| ENSG00000189223.9 |
Motesanib |
Liver hepatocellular carcinoma |
0.028519172 |
Sensitive |
| ENSG00000228412.2 |
Motesanib |
Liver hepatocellular carcinoma |
0.035906123 |
Sensitive |
| ENSG00000230269.2 |
Motesanib |
Liver hepatocellular carcinoma |
0.019772554 |
Sensitive |
| ENSG00000230806.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.02440265 |
Sensitive |
| ENSG00000231154.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.01645465 |
Sensitive |
| ENSG00000231312.2 |
Motesanib |
Liver hepatocellular carcinoma |
0.000662159 |
Sensitive |
| ENSG00000234311.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.024784503 |
Sensitive |
| ENSG00000235426.2 |
Motesanib |
Liver hepatocellular carcinoma |
0.045465387 |
Sensitive |
| ENSG00000236943.2 |
Motesanib |
Liver hepatocellular carcinoma |
0.039379003 |
Sensitive |
| ENSG00000237903.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.040960557 |
Sensitive |
| ENSG00000238005.2 |
Motesanib |
Liver hepatocellular carcinoma |
0.038645796 |
Sensitive |
| ENSG00000242349.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.043414438 |
Sensitive |
| ENSG00000249406.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.022045149 |
Sensitive |
| ENSG00000251361.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.001239795 |
Sensitive |
| ENSG00000253552.3 |
Motesanib |
Liver hepatocellular carcinoma |
0.011317199 |
Sensitive |
| ENSG00000255717.2 |
Motesanib |
Liver hepatocellular carcinoma |
0.016525814 |
Sensitive |
| ENSG00000257894.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.011886813 |
Sensitive |
| ENSG00000258334.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.043399106 |
Sensitive |
| ENSG00000259038.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.002687183 |
Sensitive |
| ENSG00000259294.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.020796156 |
Sensitive |
| ENSG00000260436.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.034870429 |
Sensitive |
| ENSG00000260572.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.042333881 |
Sensitive |
| ENSG00000261051.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.029096391 |
Sensitive |
| ENSG00000261270.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.035486624 |
Sensitive |
| ENSG00000265943.1 |
Motesanib |
Liver hepatocellular carcinoma |
0.030330013 |
Sensitive |
| ENSG00000088970.11 |
Motesanib |
Lung squamous cell carcinoma |
0.017420933 |
Sensitive |
| ENSG00000170846.11 |
Motesanib |
Lung squamous cell carcinoma |
0.049324954 |
Sensitive |
| ENSG00000177337.3 |
Motesanib |
Lung squamous cell carcinoma |
0.029483786 |
Sensitive |
| ENSG00000179523.4 |
Motesanib |
Lung squamous cell carcinoma |
0.003298877 |
Sensitive |
| ENSG00000179818.9 |
Motesanib |
Lung squamous cell carcinoma |
0.006712861 |
Sensitive |
| ENSG00000179935.5 |
Motesanib |
Lung squamous cell carcinoma |
0.038052796 |
Sensitive |
| ENSG00000181798.2 |
Motesanib |
Lung squamous cell carcinoma |
0.001844665 |
Sensitive |
| ENSG00000185203.7 |
Motesanib |
Lung squamous cell carcinoma |
0.023462321 |
Sensitive |
| ENSG00000185433.4 |
Motesanib |
Lung squamous cell carcinoma |
0.036107863 |
Sensitive |
| ENSG00000185837.3 |
Motesanib |
Lung squamous cell carcinoma |
0.012745605 |
Sensitive |
| ENSG00000196553.9 |
Motesanib |
Lung squamous cell carcinoma |
0.010028765 |
Sensitive |
| ENSG00000197813.4 |
Motesanib |
Lung squamous cell carcinoma |
0.038979415 |
Sensitive |
| ENSG00000203620.2 |
Motesanib |
Lung squamous cell carcinoma |
0.033914614 |
Sensitive |
| ENSG00000203865.5 |
Motesanib |
Lung squamous cell carcinoma |
0.041069553 |
Sensitive |
| ENSG00000203999.4 |
Motesanib |
Lung squamous cell carcinoma |
0.044023873 |
Sensitive |
| ENSG00000204044.5 |
Motesanib |
Lung squamous cell carcinoma |
0.005748899 |
Sensitive |
| ENSG00000205488.4 |
Motesanib |
Lung squamous cell carcinoma |
0.048972324 |
Sensitive |
| ENSG00000205885.3 |
Motesanib |
Lung squamous cell carcinoma |
0.004332216 |
Sensitive |
| ENSG00000206140.5 |
Motesanib |
Lung squamous cell carcinoma |
0.00172305 |
Sensitive |
| ENSG00000206176.5 |
Motesanib |
Lung squamous cell carcinoma |
0.02339199 |
Sensitive |
| ENSG00000206195.6 |
Motesanib |
Lung squamous cell carcinoma |
0.008684739 |
Sensitive |
| ENSG00000212552.2 |
Motesanib |
Lung squamous cell carcinoma |
0.038459462 |
Sensitive |
| ENSG00000214614.2 |
Motesanib |
Lung squamous cell carcinoma |
0.047941467 |
Sensitive |
| ENSG00000215394.4 |
Motesanib |
Lung squamous cell carcinoma |
0.044869979 |
Sensitive |
| ENSG00000215863.2 |
Motesanib |
Lung squamous cell carcinoma |
0.024251898 |
Sensitive |
| ENSG00000223396.2 |
Motesanib |
Lung squamous cell carcinoma |
0.037643007 |
Sensitive |
| ENSG00000223511.1 |
Motesanib |
Lung squamous cell carcinoma |
0.043267989 |
Sensitive |
| ENSG00000223598.1 |
Motesanib |
Lung squamous cell carcinoma |
0.037032499 |
Sensitive |
| ENSG00000223695.1 |
Motesanib |
Lung squamous cell carcinoma |
0.015143601 |
Sensitive |
| ENSG00000223734.2 |
Motesanib |
Lung squamous cell carcinoma |
0.046814846 |
Sensitive |
| ENSG00000223745.3 |
Motesanib |
Lung squamous cell carcinoma |
0.023155603 |
Sensitive |
| ENSG00000223759.2 |
Motesanib |
Lung squamous cell carcinoma |
0.017650476 |
Sensitive |
| ENSG00000224481.1 |
Motesanib |
Lung squamous cell carcinoma |
0.04431695 |
Sensitive |
| ENSG00000224509.1 |
Motesanib |
Lung squamous cell carcinoma |
0.014744894 |
Sensitive |
| ENSG00000224536.1 |
Motesanib |
Lung squamous cell carcinoma |
0.021870753 |
Sensitive |
| ENSG00000224687.1 |
Motesanib |
Lung squamous cell carcinoma |
0.043331955 |
Sensitive |
| ENSG00000224699.4 |
Motesanib |
Lung squamous cell carcinoma |
0.001663611 |
Sensitive |
| ENSG00000224707.1 |
Motesanib |
Lung squamous cell carcinoma |
0.007561789 |
Sensitive |
| ENSG00000224729.4 |
Motesanib |
Lung squamous cell carcinoma |
0.048090066 |
Sensitive |
| ENSG00000224790.1 |
Motesanib |
Lung squamous cell carcinoma |
0.045948681 |
Sensitive |
| ENSG00000225210.5 |
Motesanib |
Lung squamous cell carcinoma |
0.012691301 |
Sensitive |
| ENSG00000225278.3 |
Motesanib |
Lung squamous cell carcinoma |
0.038609022 |
Sensitive |
| ENSG00000225506.2 |
Motesanib |
Lung squamous cell carcinoma |
0.002660756 |
Sensitive |
| ENSG00000225578.1 |
Motesanib |
Lung squamous cell carcinoma |
0.006036541 |
Sensitive |
| ENSG00000225595.2 |
Motesanib |
Lung squamous cell carcinoma |
0.011929557 |
Sensitive |
| ENSG00000225839.2 |
Motesanib |
Lung squamous cell carcinoma |
0.04721889 |
Sensitive |
| ENSG00000226009.1 |
Motesanib |
Lung squamous cell carcinoma |
0.009736522 |
Sensitive |
| ENSG00000226067.2 |
Motesanib |
Lung squamous cell carcinoma |
0.020662799 |
Sensitive |
| ENSG00000226609.1 |
Motesanib |
Lung squamous cell carcinoma |
0.019878924 |
Sensitive |
| ENSG00000227047.1 |
Motesanib |
Lung squamous cell carcinoma |
0.048774572 |
Sensitive |
| ENSG00000227215.1 |
Motesanib |
Lung squamous cell carcinoma |
0.015479937 |
Sensitive |
| ENSG00000227354.2 |
Motesanib |
Lung squamous cell carcinoma |
0.028874647 |
Sensitive |
| ENSG00000227492.1 |
Motesanib |
Lung squamous cell carcinoma |
0.045916952 |
Sensitive |
| ENSG00000227533.1 |
Motesanib |
Lung squamous cell carcinoma |
0.039642129 |
Sensitive |
| ENSG00000227579.1 |
Motesanib |
Lung squamous cell carcinoma |
0.018237717 |
Sensitive |
| ENSG00000227627.1 |
Motesanib |
Lung squamous cell carcinoma |
0.009998046 |
Sensitive |
| ENSG00000227634.1 |
Motesanib |
Lung squamous cell carcinoma |
0.011419858 |
Sensitive |
| ENSG00000227640.2 |
Motesanib |
Lung squamous cell carcinoma |
0.029063507 |
Sensitive |
| ENSG00000227676.2 |
Motesanib |
Lung squamous cell carcinoma |
0.047710693 |
Sensitive |
| ENSG00000228107.1 |
Motesanib |
Lung squamous cell carcinoma |
0.027981653 |
Sensitive |
| ENSG00000228124.1 |
Motesanib |
Lung squamous cell carcinoma |
0.028152553 |
Sensitive |
| ENSG00000228237.1 |
Motesanib |
Lung squamous cell carcinoma |
0.020877257 |
Sensitive |
| ENSG00000228294.2 |
Motesanib |
Lung squamous cell carcinoma |
0.02377589 |
Sensitive |
| ENSG00000228393.3 |
Motesanib |
Lung squamous cell carcinoma |
0.002112673 |
Sensitive |
| ENSG00000228718.1 |
Motesanib |
Lung squamous cell carcinoma |
0.034615404 |
Sensitive |
| ENSG00000228719.1 |
Motesanib |
Lung squamous cell carcinoma |
0.022737041 |
Sensitive |
| ENSG00000228775.3 |
Motesanib |
Lung squamous cell carcinoma |
0.048263502 |
Sensitive |
| ENSG00000228809.1 |
Motesanib |
Lung squamous cell carcinoma |
0.0478257 |
Sensitive |
| ENSG00000228839.1 |
Motesanib |
Lung squamous cell carcinoma |
0.035262926 |
Sensitive |
| ENSG00000228852.2 |
Motesanib |
Lung squamous cell carcinoma |
0.022070443 |
Sensitive |
| ENSG00000229021.2 |
Motesanib |
Lung squamous cell carcinoma |
0.022611505 |
Sensitive |
| ENSG00000229263.1 |
Motesanib |
Lung squamous cell carcinoma |
0.038668349 |
Sensitive |
| ENSG00000229348.1 |
Motesanib |
Lung squamous cell carcinoma |
0.020599127 |
Sensitive |
| ENSG00000229839.2 |
Motesanib |
Lung squamous cell carcinoma |
0.033238945 |
Sensitive |
| ENSG00000230024.1 |
Motesanib |
Lung squamous cell carcinoma |
0.014715202 |
Sensitive |
| ENSG00000230054.1 |
Motesanib |
Lung squamous cell carcinoma |
0.029116175 |
Sensitive |
| ENSG00000230061.1 |
Motesanib |
Lung squamous cell carcinoma |
0.014908845 |
Sensitive |
| ENSG00000230133.1 |
Motesanib |
Lung squamous cell carcinoma |
0.03224554 |
Sensitive |
| ENSG00000230289.1 |
Motesanib |
Lung squamous cell carcinoma |
0.011992787 |
Sensitive |
| ENSG00000230550.1 |
Motesanib |
Lung squamous cell carcinoma |
0.023336831 |
Sensitive |
| ENSG00000230658.1 |
Motesanib |
Lung squamous cell carcinoma |
0.021202915 |
Sensitive |
| ENSG00000230663.1 |
Motesanib |
Lung squamous cell carcinoma |
0.028183755 |
Sensitive |
| ENSG00000230732.3 |
Motesanib |
Lung squamous cell carcinoma |
0.02014387 |
Sensitive |
| ENSG00000230815.1 |
Motesanib |
Lung squamous cell carcinoma |
0.019806869 |
Sensitive |
| ENSG00000231057.3 |
Motesanib |
Lung squamous cell carcinoma |
0.029062713 |
Sensitive |
| ENSG00000231081.1 |
Motesanib |
Lung squamous cell carcinoma |
0.03958393 |
Sensitive |
| ENSG00000231104.4 |
Motesanib |
Lung squamous cell carcinoma |
0.019783099 |
Sensitive |
| ENSG00000231439.3 |
Motesanib |
Lung squamous cell carcinoma |
0.027995054 |
Sensitive |
| ENSG00000231507.1 |
Motesanib |
Lung squamous cell carcinoma |
0.049210735 |
Sensitive |
| ENSG00000231521.1 |
Motesanib |
Lung squamous cell carcinoma |
0.021577549 |
Sensitive |
| ENSG00000231551.2 |
Motesanib |
Lung squamous cell carcinoma |
0.005226265 |
Sensitive |
| ENSG00000231609.1 |
Motesanib |
Lung squamous cell carcinoma |
0.017407764 |
Sensitive |
| ENSG00000231709.1 |
Motesanib |
Lung squamous cell carcinoma |
0.016596444 |
Sensitive |
| ENSG00000231734.4 |
Motesanib |
Lung squamous cell carcinoma |
0.025514813 |
Sensitive |
| ENSG00000231760.2 |
Motesanib |
Lung squamous cell carcinoma |
0.035749504 |
Sensitive |
| ENSG00000231842.1 |
Motesanib |
Lung squamous cell carcinoma |
0.03695678 |
Sensitive |
| ENSG00000232019.1 |
Motesanib |
Lung squamous cell carcinoma |
0.045472739 |
Sensitive |
| ENSG00000232077.1 |
Motesanib |
Lung squamous cell carcinoma |
0.011445597 |
Sensitive |
| ENSG00000232710.1 |
Motesanib |
Lung squamous cell carcinoma |
0.033007152 |
Sensitive |
| ENSG00000232712.2 |
Motesanib |
Lung squamous cell carcinoma |
0.017413375 |
Sensitive |
| ENSG00000232973.7 |
Motesanib |
Lung squamous cell carcinoma |
0.023569052 |
Sensitive |
| ENSG00000233013.4 |
Motesanib |
Lung squamous cell carcinoma |
0.04913334 |
Sensitive |
| ENSG00000233077.1 |
Motesanib |
Lung squamous cell carcinoma |
0.045947539 |
Sensitive |
| ENSG00000233184.2 |
Motesanib |
Lung squamous cell carcinoma |
0.030421134 |
Sensitive |
| ENSG00000233237.2 |
Motesanib |
Lung squamous cell carcinoma |
0.042728047 |
Sensitive |
| ENSG00000233387.1 |
Motesanib |
Lung squamous cell carcinoma |
0.046412971 |
Sensitive |
| ENSG00000233611.3 |
Motesanib |
Lung squamous cell carcinoma |
0.004603669 |
Sensitive |
| ENSG00000233785.1 |
Motesanib |
Lung squamous cell carcinoma |
0.029226336 |
Sensitive |
| ENSG00000233791.1 |
Motesanib |
Lung squamous cell carcinoma |
0.040546714 |
Sensitive |
| ENSG00000233895.1 |
Motesanib |
Lung squamous cell carcinoma |
0.024146847 |
Sensitive |
| ENSG00000233967.2 |
Motesanib |
Lung squamous cell carcinoma |
0.028195589 |
Sensitive |
| ENSG00000234050.1 |
Motesanib |
Lung squamous cell carcinoma |
0.033411244 |
Sensitive |
| ENSG00000234509.1 |
Motesanib |
Lung squamous cell carcinoma |
0.009204766 |
Sensitive |
| ENSG00000234617.1 |
Motesanib |
Lung squamous cell carcinoma |
0.022061827 |
Sensitive |
| ENSG00000234684.2 |
Motesanib |
Lung squamous cell carcinoma |
0.030063551 |
Sensitive |
| ENSG00000234694.1 |
Motesanib |
Lung squamous cell carcinoma |
0.022118601 |
Sensitive |
| ENSG00000234902.2 |
Motesanib |
Lung squamous cell carcinoma |
0.01460716 |
Sensitive |
| ENSG00000234912.5 |
Motesanib |
Lung squamous cell carcinoma |
0.000342528 |
Sensitive |
| ENSG00000235117.2 |
Motesanib |
Lung squamous cell carcinoma |
0.024701164 |
Sensitive |
| ENSG00000235373.1 |
Motesanib |
Lung squamous cell carcinoma |
0.010533464 |
Sensitive |
| ENSG00000235381.1 |
Motesanib |
Lung squamous cell carcinoma |
0.03886102 |
Sensitive |
| ENSG00000235398.4 |
Motesanib |
Lung squamous cell carcinoma |
0.046892549 |
Sensitive |
| ENSG00000235522.2 |
Motesanib |
Lung squamous cell carcinoma |
0.044778321 |
Sensitive |
| ENSG00000235527.2 |
Motesanib |
Lung squamous cell carcinoma |
0.007562739 |
Sensitive |
| ENSG00000235703.1 |
Motesanib |
Lung squamous cell carcinoma |
0.025662128 |
Sensitive |
| ENSG00000235806.1 |
Motesanib |
Lung squamous cell carcinoma |
0.024702082 |
Sensitive |
| ENSG00000235823.1 |
Motesanib |
Lung squamous cell carcinoma |
0.031576712 |
Sensitive |
| ENSG00000235831.2 |
Motesanib |
Lung squamous cell carcinoma |
0.037655935 |
Sensitive |
| ENSG00000235999.1 |
Motesanib |
Lung squamous cell carcinoma |
0.00826197 |
Sensitive |
| ENSG00000236144.2 |
Motesanib |
Lung squamous cell carcinoma |
0.037794113 |
Sensitive |
| ENSG00000236200.1 |
Motesanib |
Lung squamous cell carcinoma |
0.025729466 |
Sensitive |
| ENSG00000236352.1 |
Motesanib |
Lung squamous cell carcinoma |
0.013292864 |
Sensitive |
| ENSG00000236358.1 |
Motesanib |
Lung squamous cell carcinoma |
0.035408719 |
Sensitive |
| ENSG00000236519.1 |
Motesanib |
Lung squamous cell carcinoma |
0.024599379 |
Sensitive |
| ENSG00000236528.1 |
Motesanib |
Lung squamous cell carcinoma |
0.008182113 |
Sensitive |
| ENSG00000236743.1 |
Motesanib |
Lung squamous cell carcinoma |
0.046230945 |
Sensitive |
| ENSG00000236751.1 |
Motesanib |
Lung squamous cell carcinoma |
0.042117453 |
Sensitive |
| ENSG00000236924.1 |
Motesanib |
Lung squamous cell carcinoma |
0.001623491 |
Sensitive |
| ENSG00000237037.5 |
Motesanib |
Lung squamous cell carcinoma |
0.015982876 |
Sensitive |
| ENSG00000237356.1 |
Motesanib |
Lung squamous cell carcinoma |
0.041749006 |
Sensitive |
| ENSG00000237491.4 |
Motesanib |
Lung squamous cell carcinoma |
0.016821117 |
Sensitive |
| ENSG00000237502.2 |
Motesanib |
Lung squamous cell carcinoma |
0.000593007 |
Sensitive |
| ENSG00000237513.1 |
Motesanib |
Lung squamous cell carcinoma |
0.048289033 |
Sensitive |
| ENSG00000237685.1 |
Motesanib |
Lung squamous cell carcinoma |
0.020329802 |
Sensitive |
| ENSG00000237689.1 |
Motesanib |
Lung squamous cell carcinoma |
0.002123549 |
Sensitive |
| ENSG00000237950.1 |
Motesanib |
Lung squamous cell carcinoma |
0.037261523 |
Sensitive |
| ENSG00000238290.1 |
Motesanib |
Lung squamous cell carcinoma |
0.01389618 |
Sensitive |
| ENSG00000239664.2 |
Motesanib |
Lung squamous cell carcinoma |
0.024927505 |
Sensitive |
| ENSG00000239705.1 |
Motesanib |
Lung squamous cell carcinoma |
0.042141187 |
Sensitive |
| ENSG00000239906.1 |
Motesanib |
Lung squamous cell carcinoma |
0.010245284 |
Sensitive |
| ENSG00000240050.1 |
Motesanib |
Lung squamous cell carcinoma |
0.029216199 |
Sensitive |
| ENSG00000240254.1 |
Motesanib |
Lung squamous cell carcinoma |
0.020556068 |
Sensitive |
| ENSG00000240440.1 |
Motesanib |
Lung squamous cell carcinoma |
0.04421271 |
Sensitive |
| ENSG00000240541.2 |
Motesanib |
Lung squamous cell carcinoma |
0.003634276 |
Sensitive |
| ENSG00000241520.1 |
Motesanib |
Lung squamous cell carcinoma |
0.025406456 |
Sensitive |
| ENSG00000241599.1 |
Motesanib |
Lung squamous cell carcinoma |
0.010212411 |
Sensitive |
| ENSG00000241860.2 |
Motesanib |
Lung squamous cell carcinoma |
0.019455425 |
Sensitive |
| ENSG00000242391.2 |
Motesanib |
Lung squamous cell carcinoma |
0.00109265 |
Sensitive |
| ENSG00000243187.1 |
Motesanib |
Lung squamous cell carcinoma |
0.046338544 |
Sensitive |
| ENSG00000243230.1 |
Motesanib |
Lung squamous cell carcinoma |
0.01023186 |
Sensitive |
| ENSG00000243819.3 |
Motesanib |
Lung squamous cell carcinoma |
0.025275605 |
Sensitive |
| ENSG00000243849.1 |
Motesanib |
Lung squamous cell carcinoma |
0.043666979 |
Sensitive |
| ENSG00000243926.1 |
Motesanib |
Lung squamous cell carcinoma |
0.046280174 |
Sensitive |
| ENSG00000244879.3 |
Motesanib |
Lung squamous cell carcinoma |
0.004530772 |
Sensitive |
| ENSG00000245248.3 |
Motesanib |
Lung squamous cell carcinoma |
0.042897251 |
Sensitive |
| ENSG00000245322.2 |
Motesanib |
Lung squamous cell carcinoma |
0.011290632 |
Sensitive |
| ENSG00000245534.2 |
Motesanib |
Lung squamous cell carcinoma |
0.018381832 |
Sensitive |
| ENSG00000245849.2 |
Motesanib |
Lung squamous cell carcinoma |
0.000195394 |
Sensitive |
| ENSG00000246174.3 |
Motesanib |
Lung squamous cell carcinoma |
0.034883673 |
Sensitive |
| ENSG00000246379.2 |
Motesanib |
Lung squamous cell carcinoma |
0.046170753 |
Sensitive |
| ENSG00000246740.2 |
Motesanib |
Lung squamous cell carcinoma |
0.046762564 |
Sensitive |
| ENSG00000246863.2 |
Motesanib |
Lung squamous cell carcinoma |
0.015930926 |
Sensitive |
| ENSG00000246889.2 |
Motesanib |
Lung squamous cell carcinoma |
0.002616444 |
Sensitive |
| ENSG00000247324.2 |
Motesanib |
Lung squamous cell carcinoma |
0.010946922 |
Sensitive |
| ENSG00000247363.2 |
Motesanib |
Lung squamous cell carcinoma |
0.037137486 |
Sensitive |
| ENSG00000247925.2 |
Motesanib |
Lung squamous cell carcinoma |
0.041709546 |
Sensitive |
| ENSG00000248131.1 |
Motesanib |
Lung squamous cell carcinoma |
0.049296481 |
Sensitive |
| ENSG00000248206.1 |
Motesanib |
Lung squamous cell carcinoma |
0.028819044 |
Sensitive |
| ENSG00000248508.2 |
Motesanib |
Lung squamous cell carcinoma |
0.001810918 |
Sensitive |
| ENSG00000248514.1 |
Motesanib |
Lung squamous cell carcinoma |
0.028330648 |
Sensitive |
| ENSG00000248671.3 |
Motesanib |
Lung squamous cell carcinoma |
0.015566332 |
Sensitive |
| ENSG00000249451.1 |
Motesanib |
Lung squamous cell carcinoma |
0.022434045 |
Sensitive |
| ENSG00000249502.1 |
Motesanib |
Lung squamous cell carcinoma |
0.029294402 |
Sensitive |
| ENSG00000249700.4 |
Motesanib |
Lung squamous cell carcinoma |
0.040213453 |
Sensitive |
| ENSG00000249786.3 |
Motesanib |
Lung squamous cell carcinoma |
0.034904244 |
Sensitive |
| ENSG00000250116.2 |
Motesanib |
Lung squamous cell carcinoma |
0.032402333 |
Sensitive |
| ENSG00000250220.1 |
Motesanib |
Lung squamous cell carcinoma |
0.040450509 |
Sensitive |
| ENSG00000250326.1 |
Motesanib |
Lung squamous cell carcinoma |
0.016346691 |
Sensitive |
| ENSG00000250790.3 |
Motesanib |
Lung squamous cell carcinoma |
0.005819201 |
Sensitive |
| ENSG00000250802.2 |
Motesanib |
Lung squamous cell carcinoma |
0.02368455 |
Sensitive |
| ENSG00000250900.2 |
Motesanib |
Lung squamous cell carcinoma |
0.009381187 |
Sensitive |
| ENSG00000251026.1 |
Motesanib |
Lung squamous cell carcinoma |
0.009977354 |
Sensitive |
| ENSG00000251136.4 |
Motesanib |
Lung squamous cell carcinoma |
0.026690288 |
Sensitive |
| ENSG00000254143.1 |
Motesanib |
Lung squamous cell carcinoma |
0.036890263 |
Sensitive |
| ENSG00000254353.1 |
Motesanib |
Lung squamous cell carcinoma |
0.020770167 |
Sensitive |
| ENSG00000254604.1 |
Motesanib |
Lung squamous cell carcinoma |
0.016592345 |
Sensitive |
| ENSG00000254631.1 |
Motesanib |
Lung squamous cell carcinoma |
0.016998389 |
Sensitive |
| ENSG00000254662.1 |
Motesanib |
Lung squamous cell carcinoma |
0.006535609 |
Sensitive |
| ENSG00000254812.1 |
Motesanib |
Lung squamous cell carcinoma |
0.019426751 |
Sensitive |
| ENSG00000254855.1 |
Motesanib |
Lung squamous cell carcinoma |
0.035879166 |
Sensitive |
| ENSG00000254885.1 |
Motesanib |
Lung squamous cell carcinoma |
0.032911617 |
Sensitive |
| ENSG00000255031.1 |
Motesanib |
Lung squamous cell carcinoma |
0.024940914 |
Sensitive |
| ENSG00000255050.1 |
Motesanib |
Lung squamous cell carcinoma |
0.033829335 |
Sensitive |
| ENSG00000255100.1 |
Motesanib |
Lung squamous cell carcinoma |
0.018905217 |
Sensitive |
| ENSG00000255165.1 |
Motesanib |
Lung squamous cell carcinoma |
0.026845478 |
Sensitive |
| ENSG00000255337.1 |
Motesanib |
Lung squamous cell carcinoma |
0.031125376 |
Sensitive |
| ENSG00000255343.1 |
Motesanib |
Lung squamous cell carcinoma |
0.046031791 |
Sensitive |
| ENSG00000255421.1 |
Motesanib |
Lung squamous cell carcinoma |
0.014582814 |
Sensitive |
| ENSG00000255458.1 |
Motesanib |
Lung squamous cell carcinoma |
0.005433566 |
Sensitive |
| ENSG00000255670.1 |
Motesanib |
Lung squamous cell carcinoma |
0.021217254 |
Sensitive |
| ENSG00000255847.1 |
Motesanib |
Lung squamous cell carcinoma |
0.036579961 |
Sensitive |
| ENSG00000255992.1 |
Motesanib |
Lung squamous cell carcinoma |
0.043595693 |
Sensitive |
| ENSG00000256146.1 |
Motesanib |
Lung squamous cell carcinoma |
0.037988737 |
Sensitive |
| ENSG00000256955.1 |
Motesanib |
Lung squamous cell carcinoma |
0.043866731 |
Sensitive |
| ENSG00000256967.1 |
Motesanib |
Lung squamous cell carcinoma |
0.028052945 |
Sensitive |
| ENSG00000257270.1 |
Motesanib |
Lung squamous cell carcinoma |
0.022726694 |
Sensitive |
| ENSG00000257449.1 |
Motesanib |
Lung squamous cell carcinoma |
0.033498909 |
Sensitive |
| ENSG00000257496.1 |
Motesanib |
Lung squamous cell carcinoma |
0.041574935 |
Sensitive |
| ENSG00000257534.1 |
Motesanib |
Lung squamous cell carcinoma |
0.020835735 |
Sensitive |
| ENSG00000257964.1 |
Motesanib |
Lung squamous cell carcinoma |
0.008391351 |
Sensitive |
| ENSG00000257999.1 |
Motesanib |
Lung squamous cell carcinoma |
0.016959535 |
Sensitive |
| ENSG00000258086.1 |
Motesanib |
Lung squamous cell carcinoma |
0.046850409 |
Sensitive |
| ENSG00000258122.1 |
Motesanib |
Lung squamous cell carcinoma |
0.032765766 |
Sensitive |
| ENSG00000258199.1 |
Motesanib |
Lung squamous cell carcinoma |
0.025546526 |
Sensitive |
| ENSG00000258260.1 |
Motesanib |
Lung squamous cell carcinoma |
0.013923649 |
Sensitive |
| ENSG00000258479.1 |
Motesanib |
Lung squamous cell carcinoma |
0.034828605 |
Sensitive |
| ENSG00000258526.1 |
Motesanib |
Lung squamous cell carcinoma |
0.043073531 |
Sensitive |
| ENSG00000258654.1 |
Motesanib |
Lung squamous cell carcinoma |
0.015674983 |
Sensitive |
| ENSG00000258658.1 |
Motesanib |
Lung squamous cell carcinoma |
0.045228133 |
Sensitive |
| ENSG00000258942.1 |
Motesanib |
Lung squamous cell carcinoma |
0.041750019 |
Sensitive |
| ENSG00000259088.1 |
Motesanib |
Lung squamous cell carcinoma |
0.015034837 |
Sensitive |
| ENSG00000259172.1 |
Motesanib |
Lung squamous cell carcinoma |
0.007022529 |
Sensitive |
| ENSG00000259212.1 |
Motesanib |
Lung squamous cell carcinoma |
0.026419911 |
Sensitive |
| ENSG00000259274.1 |
Motesanib |
Lung squamous cell carcinoma |
0.023857111 |
Sensitive |
| ENSG00000259298.1 |
Motesanib |
Lung squamous cell carcinoma |
0.037003192 |
Sensitive |
| ENSG00000259396.1 |
Motesanib |
Lung squamous cell carcinoma |
0.008273702 |
Sensitive |
| ENSG00000259408.1 |
Motesanib |
Lung squamous cell carcinoma |
0.035151253 |
Sensitive |
| ENSG00000259424.1 |
Motesanib |
Lung squamous cell carcinoma |
0.031958363 |
Sensitive |
| ENSG00000259475.1 |
Motesanib |
Lung squamous cell carcinoma |
0.012173793 |
Sensitive |
| ENSG00000259520.1 |
Motesanib |
Lung squamous cell carcinoma |
0.031884728 |
Sensitive |
| ENSG00000259583.1 |
Motesanib |
Lung squamous cell carcinoma |
0.04484093 |
Sensitive |
| ENSG00000259635.1 |
Motesanib |
Lung squamous cell carcinoma |
0.019899534 |
Sensitive |
| ENSG00000259715.1 |
Motesanib |
Lung squamous cell carcinoma |
0.024451356 |
Sensitive |
| ENSG00000259727.1 |
Motesanib |
Lung squamous cell carcinoma |
0.03310816 |
Sensitive |
| ENSG00000259802.1 |
Motesanib |
Lung squamous cell carcinoma |
0.024569519 |
Sensitive |
| ENSG00000260198.1 |
Motesanib |
Lung squamous cell carcinoma |
0.001478719 |
Sensitive |
| ENSG00000260261.1 |
Motesanib |
Lung squamous cell carcinoma |
0.041027238 |
Sensitive |
| ENSG00000260273.1 |
Motesanib |
Lung squamous cell carcinoma |
0.025940023 |
Sensitive |
| ENSG00000260285.1 |
Motesanib |
Lung squamous cell carcinoma |
0.012412825 |
Sensitive |
| ENSG00000260288.2 |
Motesanib |
Lung squamous cell carcinoma |
0.033987485 |
Sensitive |
| ENSG00000260351.1 |
Motesanib |
Lung squamous cell carcinoma |
0.008184519 |
Sensitive |
| ENSG00000260495.1 |
Motesanib |
Lung squamous cell carcinoma |
0.006470276 |
Sensitive |
| ENSG00000260528.2 |
Motesanib |
Lung squamous cell carcinoma |
0.049248574 |
Sensitive |
| ENSG00000260563.2 |
Motesanib |
Lung squamous cell carcinoma |
0.037130719 |
Sensitive |
| ENSG00000260643.1 |
Motesanib |
Lung squamous cell carcinoma |
0.012030955 |
Sensitive |
| ENSG00000260645.1 |
Motesanib |
Lung squamous cell carcinoma |
0.049637227 |
Sensitive |
| ENSG00000260757.1 |
Motesanib |
Lung squamous cell carcinoma |
0.025783527 |
Sensitive |
| ENSG00000260949.1 |
Motesanib |
Lung squamous cell carcinoma |
0.033384645 |
Sensitive |
| ENSG00000260988.1 |
Motesanib |
Lung squamous cell carcinoma |
0.001443297 |
Sensitive |
| ENSG00000261039.1 |
Motesanib |
Lung squamous cell carcinoma |
0.043051823 |
Sensitive |
| ENSG00000261043.2 |
Motesanib |
Lung squamous cell carcinoma |
0.032069452 |
Sensitive |
| ENSG00000261126.3 |
Motesanib |
Lung squamous cell carcinoma |
0.014129123 |
Sensitive |
| ENSG00000261189.1 |
Motesanib |
Lung squamous cell carcinoma |
0.036051432 |
Sensitive |
| ENSG00000261204.1 |
Motesanib |
Lung squamous cell carcinoma |
0.021656334 |
Sensitive |
| ENSG00000261242.1 |
Motesanib |
Lung squamous cell carcinoma |
0.026358879 |
Sensitive |
| ENSG00000261252.1 |
Motesanib |
Lung squamous cell carcinoma |
0.032661788 |
Sensitive |
| ENSG00000261302.1 |
Motesanib |
Lung squamous cell carcinoma |
0.031191524 |
Sensitive |
| ENSG00000261360.1 |
Motesanib |
Lung squamous cell carcinoma |
0.005921317 |
Sensitive |
| ENSG00000261366.1 |
Motesanib |
Lung squamous cell carcinoma |
0.049967876 |
Sensitive |
| ENSG00000261433.1 |
Motesanib |
Lung squamous cell carcinoma |
0.049419955 |
Sensitive |
| ENSG00000261775.1 |
Motesanib |
Lung squamous cell carcinoma |
0.027554518 |
Sensitive |
| ENSG00000261798.1 |
Motesanib |
Lung squamous cell carcinoma |
0.003693669 |
Sensitive |
| ENSG00000261879.1 |
Motesanib |
Lung squamous cell carcinoma |
0.001262661 |
Sensitive |
| ENSG00000261886.1 |
Motesanib |
Lung squamous cell carcinoma |
0.004588223 |
Sensitive |
| ENSG00000262001.1 |
Motesanib |
Lung squamous cell carcinoma |
0.000453764 |
Sensitive |
| ENSG00000262136.1 |
Motesanib |
Lung squamous cell carcinoma |
0.015216587 |
Sensitive |
| ENSG00000262155.1 |
Motesanib |
Lung squamous cell carcinoma |
0.034991085 |
Sensitive |
| ENSG00000262213.1 |
Motesanib |
Lung squamous cell carcinoma |
0.012801783 |
Sensitive |
| ENSG00000262298.1 |
Motesanib |
Lung squamous cell carcinoma |
0.000271921 |
Sensitive |
| ENSG00000262668.1 |
Motesanib |
Lung squamous cell carcinoma |
0.044155807 |
Sensitive |
| ENSG00000263004.1 |
Motesanib |
Lung squamous cell carcinoma |
0.048633641 |
Sensitive |
| ENSG00000263164.1 |
Motesanib |
Lung squamous cell carcinoma |
0.018816878 |
Sensitive |
| ENSG00000263272.1 |
Motesanib |
Lung squamous cell carcinoma |
0.014305732 |
Sensitive |
| ENSG00000263345.1 |
Motesanib |
Lung squamous cell carcinoma |
0.009057374 |
Sensitive |
| ENSG00000263412.1 |
Motesanib |
Lung squamous cell carcinoma |
0.042752175 |
Sensitive |
| ENSG00000264339.1 |
Motesanib |
Lung squamous cell carcinoma |
0.011885201 |
Sensitive |
| ENSG00000264548.1 |
Motesanib |
Lung squamous cell carcinoma |
0.017247497 |
Sensitive |
| ENSG00000264635.1 |
Motesanib |
Lung squamous cell carcinoma |
0.031918588 |
Sensitive |
| ENSG00000264769.1 |
Motesanib |
Lung squamous cell carcinoma |
0.00172847 |
Sensitive |
| ENSG00000264812.1 |
Motesanib |
Lung squamous cell carcinoma |
0.012054049 |
Sensitive |
| ENSG00000265349.1 |
Motesanib |
Lung squamous cell carcinoma |
0.017605499 |
Sensitive |
| ENSG00000265399.1 |
Motesanib |
Lung squamous cell carcinoma |
0.024235043 |
Sensitive |
| ENSG00000266126.1 |
Motesanib |
Lung squamous cell carcinoma |
0.003133119 |
Sensitive |
| ENSG00000266313.1 |
Motesanib |
Lung squamous cell carcinoma |
0.00283386 |
Sensitive |
| ENSG00000266401.1 |
Motesanib |
Lung squamous cell carcinoma |
0.001096404 |
Sensitive |
| ENSG00000266803.1 |
Motesanib |
Lung squamous cell carcinoma |
0.043109617 |
Sensitive |
| ENSG00000266821.1 |
Motesanib |
Lung squamous cell carcinoma |
0.0118523 |
Sensitive |
| ENSG00000266904.1 |
Motesanib |
Lung squamous cell carcinoma |
0.033832422 |
Sensitive |
| ENSG00000266913.1 |
Motesanib |
Lung squamous cell carcinoma |
0.048308836 |
Sensitive |
| ENSG00000266970.1 |
Motesanib |
Lung squamous cell carcinoma |
0.009667765 |
Sensitive |
| ENSG00000267018.1 |
Motesanib |
Lung squamous cell carcinoma |
0.025078633 |
Sensitive |
| ENSG00000267104.1 |
Motesanib |
Lung squamous cell carcinoma |
0.000828405 |
Sensitive |
| ENSG00000267141.1 |
Motesanib |
Lung squamous cell carcinoma |
0.047592817 |
Sensitive |
| ENSG00000267144.1 |
Motesanib |
Lung squamous cell carcinoma |
0.042880885 |
Sensitive |
| ENSG00000267149.2 |
Motesanib |
Lung squamous cell carcinoma |
0.011094569 |
Sensitive |
| ENSG00000267166.1 |
Motesanib |
Lung squamous cell carcinoma |
0.025722913 |
Sensitive |
| ENSG00000267230.1 |
Motesanib |
Lung squamous cell carcinoma |
0.045387621 |
Sensitive |
| ENSG00000267272.1 |
Motesanib |
Lung squamous cell carcinoma |
0.01223103 |
Sensitive |
| ENSG00000267278.1 |
Motesanib |
Lung squamous cell carcinoma |
0.005180492 |
Sensitive |
| ENSG00000267302.1 |
Motesanib |
Lung squamous cell carcinoma |
0.010572605 |
Sensitive |
| ENSG00000267347.1 |
Motesanib |
Lung squamous cell carcinoma |
0.043824728 |
Sensitive |
| ENSG00000267388.1 |
Motesanib |
Lung squamous cell carcinoma |
0.046415107 |
Sensitive |
| ENSG00000267432.1 |
Motesanib |
Lung squamous cell carcinoma |
0.040920604 |
Sensitive |
| ENSG00000267627.1 |
Motesanib |
Lung squamous cell carcinoma |
0.031195685 |
Sensitive |
| ENSG00000267751.1 |
Motesanib |
Lung squamous cell carcinoma |
0.019601139 |
Sensitive |
| ENSG00000267852.1 |
Motesanib |
Lung squamous cell carcinoma |
0.015147245 |
Sensitive |
| ENSG00000268157.1 |
Motesanib |
Lung squamous cell carcinoma |
0.01622578 |
Sensitive |
| ENSG00000268655.1 |
Motesanib |
Lung squamous cell carcinoma |
0.022915087 |
Sensitive |
| ENSG00000269054.1 |
Motesanib |
Lung squamous cell carcinoma |
0.016421323 |
Sensitive |
| ENSG00000269161.1 |
Motesanib |
Lung squamous cell carcinoma |
0.013640609 |
Sensitive |
| ENSG00000269194.1 |
Motesanib |
Lung squamous cell carcinoma |
0.007351587 |
Sensitive |
| ENSG00000269220.1 |
Motesanib |
Lung squamous cell carcinoma |
0.02544512 |
Sensitive |
| ENSG00000269392.1 |
Motesanib |
Lung squamous cell carcinoma |
0.01543653 |
Sensitive |
| ENSG00000269694.1 |
Motesanib |
Lung squamous cell carcinoma |
0.007734882 |
Sensitive |
| ENSG00000269707.1 |
Motesanib |
Lung squamous cell carcinoma |
0.042918139 |
Sensitive |
| ENSG00000269895.1 |
Motesanib |
Lung squamous cell carcinoma |
0.047097162 |
Sensitive |
| ENSG00000269898.1 |
Motesanib |
Lung squamous cell carcinoma |
0.036621679 |
Sensitive |
| ENSG00000269947.1 |
Motesanib |
Lung squamous cell carcinoma |
0.002833262 |
Sensitive |
| ENSG00000269980.1 |
Motesanib |
Lung squamous cell carcinoma |
0.041804081 |
Sensitive |
| ENSG00000269983.1 |
Motesanib |
Lung squamous cell carcinoma |
0.015335658 |
Sensitive |
| ENSG00000270019.1 |
Motesanib |
Lung squamous cell carcinoma |
0.049911135 |
Sensitive |
| ENSG00000270115.1 |
Motesanib |
Lung squamous cell carcinoma |
0.024811737 |
Sensitive |
| ENSG00000270116.1 |
Motesanib |
Lung squamous cell carcinoma |
0.035516979 |
Sensitive |
| ENSG00000270165.1 |
Motesanib |
Lung squamous cell carcinoma |
0.002854853 |
Sensitive |
| ENSG00000270426.1 |
Motesanib |
Lung squamous cell carcinoma |
0.041868034 |
Sensitive |
| ENSG00000270726.1 |
Motesanib |
Lung squamous cell carcinoma |
0.035337356 |
Sensitive |
| ENSG00000271119.1 |
Motesanib |
Lung squamous cell carcinoma |
0.037631756 |
Sensitive |
| ENSG00000271151.1 |
Motesanib |
Lung squamous cell carcinoma |
0.032010145 |
Sensitive |
| ENSG00000271335.1 |
Motesanib |
Lung squamous cell carcinoma |
0.003038822 |
Sensitive |
| ENSG00000271855.1 |
Motesanib |
Lung squamous cell carcinoma |
0.038528073 |
Sensitive |
| ENSG00000271938.1 |
Motesanib |
Lung squamous cell carcinoma |
0.04351775 |
Sensitive |
| ENSG00000271978.1 |
Motesanib |
Lung squamous cell carcinoma |
0.035457107 |
Sensitive |
| ENSG00000272128.1 |
Motesanib |
Lung squamous cell carcinoma |
0.044484496 |
Sensitive |
| ENSG00000272455.1 |
Motesanib |
Lung squamous cell carcinoma |
0.008706537 |
Sensitive |
| ENSG00000272508.1 |
Motesanib |
Lung squamous cell carcinoma |
0.04564342 |
Sensitive |
| ENSG00000272631.1 |
Motesanib |
Lung squamous cell carcinoma |
0.001312583 |
Sensitive |
| ENSG00000272688.1 |
Motesanib |
Lung squamous cell carcinoma |
0.026919608 |
Sensitive |
| ENSG00000272709.1 |
Motesanib |
Lung squamous cell carcinoma |
0.033439507 |
Sensitive |
| ENSG00000272769.1 |
Motesanib |
Lung squamous cell carcinoma |
0.00606755 |
Sensitive |
| ENSG00000272872.1 |
Motesanib |
Lung squamous cell carcinoma |
0.006657923 |
Sensitive |
| ENSG00000272902.1 |
Motesanib |
Lung squamous cell carcinoma |
0.002584567 |
Sensitive |
| ENSG00000272949.1 |
Motesanib |
Lung squamous cell carcinoma |
0.031529343 |
Sensitive |
| ENSG00000272971.1 |
Motesanib |
Lung squamous cell carcinoma |
0.012854278 |
Sensitive |
| ENSG00000273006.1 |
Motesanib |
Lung squamous cell carcinoma |
0.045105979 |
Sensitive |
| ENSG00000273030.1 |
Motesanib |
Lung squamous cell carcinoma |
0.003438387 |
Sensitive |
| ENSG00000273145.1 |
Motesanib |
Lung squamous cell carcinoma |
0.043310805 |
Sensitive |
| ENSG00000273148.1 |
Motesanib |
Lung squamous cell carcinoma |
0.045446356 |
Sensitive |
| ENSG00000273265.1 |
Motesanib |
Lung squamous cell carcinoma |
0.002989614 |
Sensitive |
| ENSG00000273367.1 |
Motesanib |
Lung squamous cell carcinoma |
0.043237846 |
Sensitive |
| ENSG00000273374.1 |
Motesanib |
Lung squamous cell carcinoma |
0.023585542 |
Sensitive |
| ENSG00000177640.11 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022298886 |
Sensitive |
| ENSG00000181798.2 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045834898 |
Sensitive |
| ENSG00000203739.3 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044400681 |
Sensitive |
| ENSG00000214773.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04809718 |
Sensitive |
| ENSG00000224020.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04770295 |
Sensitive |
| ENSG00000224259.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.0299841 |
Sensitive |
| ENSG00000224505.2 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000956276 |
Sensitive |
| ENSG00000224533.3 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044308711 |
Sensitive |
| ENSG00000225300.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017960318 |
Sensitive |
| ENSG00000225783.2 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023792924 |
Sensitive |
| ENSG00000226363.3 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028010843 |
Sensitive |
| ENSG00000227220.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007291087 |
Sensitive |
| ENSG00000227258.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037700454 |
Sensitive |
| ENSG00000227388.2 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021790907 |
Sensitive |
| ENSG00000228661.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049794907 |
Sensitive |
| ENSG00000230424.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008532311 |
Sensitive |
| ENSG00000231312.2 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048221429 |
Sensitive |
| ENSG00000231473.2 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042370662 |
Sensitive |
| ENSG00000231530.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037081221 |
Sensitive |
| ENSG00000231551.2 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036393332 |
Sensitive |
| ENSG00000231652.2 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040478592 |
Sensitive |
| ENSG00000232063.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043952863 |
Sensitive |
| ENSG00000232377.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036443451 |
Sensitive |
| ENSG00000232876.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016730643 |
Sensitive |
| ENSG00000233137.2 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008549481 |
Sensitive |
| ENSG00000234509.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017383659 |
Sensitive |
| ENSG00000234917.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040371976 |
Sensitive |
| ENSG00000235888.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033261608 |
Sensitive |
| ENSG00000236824.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017377171 |
Sensitive |
| ENSG00000236953.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033875813 |
Sensitive |
| ENSG00000237609.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020169297 |
Sensitive |
| ENSG00000240050.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017221691 |
Sensitive |
| ENSG00000240440.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024229164 |
Sensitive |
| ENSG00000243389.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024575686 |
Sensitive |
| ENSG00000246695.3 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03569976 |
Sensitive |
| ENSG00000248027.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.003797777 |
Sensitive |
| ENSG00000248476.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.004044643 |
Sensitive |
| ENSG00000248508.2 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023293341 |
Sensitive |
| ENSG00000249916.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039408953 |
Sensitive |
| ENSG00000250616.2 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043086824 |
Sensitive |
| ENSG00000250790.3 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039136803 |
Sensitive |
| ENSG00000253948.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03795936 |
Sensitive |
| ENSG00000254207.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022967614 |
Sensitive |
| ENSG00000254635.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.004003824 |
Sensitive |
| ENSG00000258675.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030584033 |
Sensitive |
| ENSG00000259209.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023655078 |
Sensitive |
| ENSG00000260011.2 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021105898 |
Sensitive |
| ENSG00000260034.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020066877 |
Sensitive |
| ENSG00000260141.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016352044 |
Sensitive |
| ENSG00000260565.2 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017798031 |
Sensitive |
| ENSG00000260742.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024838063 |
Sensitive |
| ENSG00000260793.2 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002236909 |
Sensitive |
| ENSG00000260796.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045629605 |
Sensitive |
| ENSG00000261008.2 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016832271 |
Sensitive |
| ENSG00000261366.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045005889 |
Sensitive |
| ENSG00000261654.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002230895 |
Sensitive |
| ENSG00000261744.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000787177 |
Sensitive |
| ENSG00000261777.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02602083 |
Sensitive |
| ENSG00000262879.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.004678201 |
Sensitive |
| ENSG00000263293.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038683649 |
Sensitive |
| ENSG00000264107.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029137322 |
Sensitive |
| ENSG00000265413.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030004921 |
Sensitive |
| ENSG00000267093.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040873844 |
Sensitive |
| ENSG00000267395.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036280726 |
Sensitive |
| ENSG00000267439.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01184071 |
Sensitive |
| ENSG00000269903.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019221419 |
Sensitive |
| ENSG00000270189.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014990936 |
Sensitive |
| ENSG00000271009.2 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043132804 |
Sensitive |
| ENSG00000271367.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.010550452 |
Sensitive |
| ENSG00000271762.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04922405 |
Sensitive |
| ENSG00000273097.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033242318 |
Sensitive |
| ENSG00000273270.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006276132 |
Sensitive |
| ENSG00000273368.1 |
Motesanib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032384528 |
Sensitive |
| ENSG00000170846.11 |
Motesanib |
Pancreatic adenocarcinoma |
0.002966405 |
Sensitive |
| ENSG00000175701.6 |
Motesanib |
Pancreatic adenocarcinoma |
0.005882545 |
Sensitive |
| ENSG00000203875.6 |
Motesanib |
Pancreatic adenocarcinoma |
0.007451714 |
Sensitive |
| ENSG00000204055.4 |
Motesanib |
Pancreatic adenocarcinoma |
0.040425926 |
Sensitive |
| ENSG00000218510.3 |
Motesanib |
Pancreatic adenocarcinoma |
0.029746632 |
Sensitive |
| ENSG00000224843.2 |
Motesanib |
Pancreatic adenocarcinoma |
0.045795775 |
Sensitive |
| ENSG00000224969.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.043359786 |
Sensitive |
| ENSG00000225177.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.014899797 |
Sensitive |
| ENSG00000225767.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.03644137 |
Sensitive |
| ENSG00000226862.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.027122523 |
Sensitive |
| ENSG00000227637.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.032919989 |
Sensitive |
| ENSG00000228634.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.040804429 |
Sensitive |
| ENSG00000228889.2 |
Motesanib |
Pancreatic adenocarcinoma |
0.04815745 |
Sensitive |
| ENSG00000229688.3 |
Motesanib |
Pancreatic adenocarcinoma |
0.00691491 |
Sensitive |
| ENSG00000230074.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.02662579 |
Sensitive |
| ENSG00000230084.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.042690178 |
Sensitive |
| ENSG00000230310.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.012245932 |
Sensitive |
| ENSG00000230530.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.022222968 |
Sensitive |
| ENSG00000232098.2 |
Motesanib |
Pancreatic adenocarcinoma |
0.034032737 |
Sensitive |
| ENSG00000233184.2 |
Motesanib |
Pancreatic adenocarcinoma |
0.019133659 |
Sensitive |
| ENSG00000234206.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.049080679 |
Sensitive |
| ENSG00000236140.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.011488763 |
Sensitive |
| ENSG00000237502.2 |
Motesanib |
Pancreatic adenocarcinoma |
0.01294555 |
Sensitive |
| ENSG00000243055.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.03978055 |
Sensitive |
| ENSG00000243479.3 |
Motesanib |
Pancreatic adenocarcinoma |
0.048379693 |
Sensitive |
| ENSG00000244998.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.021193946 |
Sensitive |
| ENSG00000246130.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.036266537 |
Sensitive |
| ENSG00000247228.2 |
Motesanib |
Pancreatic adenocarcinoma |
0.024912497 |
Sensitive |
| ENSG00000247556.2 |
Motesanib |
Pancreatic adenocarcinoma |
0.027000346 |
Sensitive |
| ENSG00000250820.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.013192464 |
Sensitive |
| ENSG00000251661.3 |
Motesanib |
Pancreatic adenocarcinoma |
0.047820794 |
Sensitive |
| ENSG00000255621.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.028791506 |
Sensitive |
| ENSG00000256312.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.022150889 |
Sensitive |
| ENSG00000256576.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.041769326 |
Sensitive |
| ENSG00000257496.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.01235509 |
Sensitive |
| ENSG00000258819.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.008155062 |
Sensitive |
| ENSG00000258821.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.03878571 |
Sensitive |
| ENSG00000258920.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.028757966 |
Sensitive |
| ENSG00000259715.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.013456299 |
Sensitive |
| ENSG00000260100.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.013575996 |
Sensitive |
| ENSG00000260536.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.028757918 |
Sensitive |
| ENSG00000260787.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.022050153 |
Sensitive |
| ENSG00000261338.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.03763456 |
Sensitive |
| ENSG00000261455.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.038084573 |
Sensitive |
| ENSG00000261534.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.029753451 |
Sensitive |
| ENSG00000261744.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.042792288 |
Sensitive |
| ENSG00000263050.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.031455456 |
Sensitive |
| ENSG00000266473.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.003731789 |
Sensitive |
| ENSG00000266930.2 |
Motesanib |
Pancreatic adenocarcinoma |
0.034540618 |
Sensitive |
| ENSG00000267296.2 |
Motesanib |
Pancreatic adenocarcinoma |
0.046994105 |
Sensitive |
| ENSG00000268006.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.038838999 |
Sensitive |
| ENSG00000269834.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.045520539 |
Sensitive |
| ENSG00000269843.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.006701801 |
Sensitive |
| ENSG00000269867.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.046307368 |
Sensitive |
| ENSG00000270210.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.045979472 |
Sensitive |
| ENSG00000271755.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.007189731 |
Sensitive |
| ENSG00000272010.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.024862647 |
Sensitive |
| ENSG00000272979.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.03323718 |
Sensitive |
| ENSG00000273001.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.031182952 |
Sensitive |
| ENSG00000273059.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.040970428 |
Sensitive |
| ENSG00000273117.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.030937132 |
Sensitive |
| ENSG00000273137.1 |
Motesanib |
Pancreatic adenocarcinoma |
0.035846149 |
Sensitive |
| ENSG00000212978.5 |
Motesanib |
Sarcoma |
0.013418834 |
Sensitive |
| ENSG00000214725.3 |
Motesanib |
Sarcoma |
0.020405634 |
Sensitive |
| ENSG00000225092.2 |
Motesanib |
Sarcoma |
0.028801933 |
Sensitive |
| ENSG00000225913.2 |
Motesanib |
Sarcoma |
0.029288039 |
Sensitive |
| ENSG00000228043.1 |
Motesanib |
Sarcoma |
0.005276077 |
Sensitive |
| ENSG00000228784.3 |
Motesanib |
Sarcoma |
0.04883965 |
Sensitive |
| ENSG00000229645.4 |
Motesanib |
Sarcoma |
0.041393301 |
Sensitive |
| ENSG00000234327.3 |
Motesanib |
Sarcoma |
0.013401465 |
Sensitive |
| ENSG00000235910.1 |
Motesanib |
Sarcoma |
0.020141136 |
Sensitive |
| ENSG00000236140.1 |
Motesanib |
Sarcoma |
0.029430947 |
Sensitive |
| ENSG00000236601.1 |
Motesanib |
Sarcoma |
0.034866489 |
Sensitive |
| ENSG00000237253.1 |
Motesanib |
Sarcoma |
0.028895791 |
Sensitive |
| ENSG00000249258.2 |
Motesanib |
Sarcoma |
0.041315993 |
Sensitive |
| ENSG00000249637.1 |
Motesanib |
Sarcoma |
0.020971944 |
Sensitive |
| ENSG00000250397.2 |
Motesanib |
Sarcoma |
0.010225006 |
Sensitive |
| ENSG00000253893.2 |
Motesanib |
Sarcoma |
0.043433086 |
Sensitive |
| ENSG00000254034.1 |
Motesanib |
Sarcoma |
0.008250778 |
Sensitive |
| ENSG00000254343.2 |
Motesanib |
Sarcoma |
0.045801373 |
Sensitive |
| ENSG00000254981.1 |
Motesanib |
Sarcoma |
0.014941171 |
Sensitive |
| ENSG00000255031.1 |
Motesanib |
Sarcoma |
0.028072474 |
Sensitive |
| ENSG00000255326.1 |
Motesanib |
Sarcoma |
0.005162744 |
Sensitive |
| ENSG00000257139.1 |
Motesanib |
Sarcoma |
0.030919383 |
Sensitive |
| ENSG00000257497.1 |
Motesanib |
Sarcoma |
0.038372455 |
Sensitive |
| ENSG00000258101.1 |
Motesanib |
Sarcoma |
0.004292258 |
Sensitive |
| ENSG00000259417.2 |
Motesanib |
Sarcoma |
0.03851409 |
Sensitive |
| ENSG00000259744.1 |
Motesanib |
Sarcoma |
0.041586392 |
Sensitive |
| ENSG00000261474.1 |
Motesanib |
Sarcoma |
0.03404758 |
Sensitive |
| ENSG00000264520.1 |
Motesanib |
Sarcoma |
0.001991993 |
Sensitive |
| ENSG00000266717.1 |
Motesanib |
Sarcoma |
0.030556956 |
Sensitive |
| ENSG00000267374.1 |
Motesanib |
Sarcoma |
0.017568233 |
Sensitive |
| ENSG00000267405.1 |
Motesanib |
Sarcoma |
0.04031349 |
Sensitive |
| ENSG00000267505.1 |
Motesanib |
Sarcoma |
0.049601039 |
Sensitive |
| ENSG00000267549.1 |
Motesanib |
Sarcoma |
0.01604828 |
Sensitive |
| ENSG00000267677.1 |
Motesanib |
Sarcoma |
0.038283505 |
Sensitive |
| ENSG00000269473.1 |
Motesanib |
Sarcoma |
0.042124564 |
Sensitive |
| ENSG00000271334.1 |
Motesanib |
Sarcoma |
0.01678642 |
Sensitive |
| ENSG00000271948.1 |
Motesanib |
Sarcoma |
0.033241955 |
Sensitive |
| ENSG00000272092.1 |
Motesanib |
Sarcoma |
0.023791377 |
Sensitive |
| ENSG00000272112.1 |
Motesanib |
Sarcoma |
0.030420315 |
Sensitive |
| ENSG00000272562.1 |
Motesanib |
Sarcoma |
0.025499963 |
Sensitive |
| ENSG00000272630.1 |
Motesanib |
Sarcoma |
0.005317431 |
Sensitive |
| ENSG00000273073.1 |
Motesanib |
Sarcoma |
0.041740534 |
Sensitive |
| ENSG00000130600.11 |
Motesanib |
Skin cutaneous melanoma |
0.042290259 |
Sensitive |
| ENSG00000174171.4 |
Motesanib |
Skin cutaneous melanoma |
0.047862544 |
Sensitive |
| ENSG00000204055.4 |
Motesanib |
Skin cutaneous melanoma |
0.021764161 |
Sensitive |
| ENSG00000223576.2 |
Motesanib |
Skin cutaneous melanoma |
0.026716497 |
Sensitive |
| ENSG00000223829.1 |
Motesanib |
Skin cutaneous melanoma |
0.027441556 |
Sensitive |
| ENSG00000224973.1 |
Motesanib |
Skin cutaneous melanoma |
0.031688973 |
Sensitive |
| ENSG00000225969.1 |
Motesanib |
Skin cutaneous melanoma |
0.031017174 |
Sensitive |
| ENSG00000226237.1 |
Motesanib |
Skin cutaneous melanoma |
0.023754862 |
Sensitive |
| ENSG00000228113.3 |
Motesanib |
Skin cutaneous melanoma |
0.035104363 |
Sensitive |
| ENSG00000229582.2 |
Motesanib |
Skin cutaneous melanoma |
0.046447146 |
Sensitive |
| ENSG00000230971.1 |
Motesanib |
Skin cutaneous melanoma |
0.021603672 |
Sensitive |
| ENSG00000232814.2 |
Motesanib |
Skin cutaneous melanoma |
0.040322793 |
Sensitive |
| ENSG00000233144.1 |
Motesanib |
Skin cutaneous melanoma |
0.015226676 |
Sensitive |
| ENSG00000233237.2 |
Motesanib |
Skin cutaneous melanoma |
0.018265583 |
Sensitive |
| ENSG00000233554.1 |
Motesanib |
Skin cutaneous melanoma |
0.047767335 |
Sensitive |
| ENSG00000234567.1 |
Motesanib |
Skin cutaneous melanoma |
0.038058617 |
Sensitive |
| ENSG00000234772.1 |
Motesanib |
Skin cutaneous melanoma |
0.015816851 |
Sensitive |
| ENSG00000237021.2 |
Motesanib |
Skin cutaneous melanoma |
0.04118546 |
Sensitive |
| ENSG00000237594.2 |
Motesanib |
Skin cutaneous melanoma |
0.015895854 |
Sensitive |
| ENSG00000237798.1 |
Motesanib |
Skin cutaneous melanoma |
0.031946124 |
Sensitive |
| ENSG00000248356.1 |
Motesanib |
Skin cutaneous melanoma |
0.017223125 |
Sensitive |
| ENSG00000248677.1 |
Motesanib |
Skin cutaneous melanoma |
0.04939547 |
Sensitive |
| ENSG00000249984.1 |
Motesanib |
Skin cutaneous melanoma |
0.038650212 |
Sensitive |
| ENSG00000253799.1 |
Motesanib |
Skin cutaneous melanoma |
0.01593492 |
Sensitive |
| ENSG00000254204.1 |
Motesanib |
Skin cutaneous melanoma |
0.048335048 |
Sensitive |
| ENSG00000254602.1 |
Motesanib |
Skin cutaneous melanoma |
0.012724939 |
Sensitive |
| ENSG00000255421.1 |
Motesanib |
Skin cutaneous melanoma |
0.025892987 |
Sensitive |
| ENSG00000256050.2 |
Motesanib |
Skin cutaneous melanoma |
0.034256549 |
Sensitive |
| ENSG00000256982.1 |
Motesanib |
Skin cutaneous melanoma |
0.049420705 |
Sensitive |
| ENSG00000257496.1 |
Motesanib |
Skin cutaneous melanoma |
0.042742661 |
Sensitive |
| ENSG00000258413.1 |
Motesanib |
Skin cutaneous melanoma |
0.009893639 |
Sensitive |
| ENSG00000258858.1 |
Motesanib |
Skin cutaneous melanoma |
0.008180115 |
Sensitive |
| ENSG00000259618.1 |
Motesanib |
Skin cutaneous melanoma |
0.02873974 |
Sensitive |
| ENSG00000259806.2 |
Motesanib |
Skin cutaneous melanoma |
0.024105418 |
Sensitive |
| ENSG00000260361.1 |
Motesanib |
Skin cutaneous melanoma |
0.033046688 |
Sensitive |
| ENSG00000260468.1 |
Motesanib |
Skin cutaneous melanoma |
0.03099801 |
Sensitive |
| ENSG00000260651.1 |
Motesanib |
Skin cutaneous melanoma |
0.037691386 |
Sensitive |
| ENSG00000260823.1 |
Motesanib |
Skin cutaneous melanoma |
0.019810292 |
Sensitive |
| ENSG00000263214.1 |
Motesanib |
Skin cutaneous melanoma |
0.007583627 |
Sensitive |
| ENSG00000264043.2 |
Motesanib |
Skin cutaneous melanoma |
0.000430645 |
Sensitive |
| ENSG00000264745.1 |
Motesanib |
Skin cutaneous melanoma |
0.016213773 |
Sensitive |
| ENSG00000267288.1 |
Motesanib |
Skin cutaneous melanoma |
0.040348028 |
Sensitive |
| ENSG00000267298.1 |
Motesanib |
Skin cutaneous melanoma |
0.014137765 |
Sensitive |
| ENSG00000267414.1 |
Motesanib |
Skin cutaneous melanoma |
0.01626551 |
Sensitive |
| ENSG00000267530.2 |
Motesanib |
Skin cutaneous melanoma |
0.043986152 |
Sensitive |
| ENSG00000267745.1 |
Motesanib |
Skin cutaneous melanoma |
0.02459478 |
Sensitive |
| ENSG00000268289.1 |
Motesanib |
Skin cutaneous melanoma |
0.043493342 |
Sensitive |
| ENSG00000273007.1 |
Motesanib |
Skin cutaneous melanoma |
0.027561536 |
Sensitive |
| ENSG00000273335.1 |
Motesanib |
Skin cutaneous melanoma |
0.036776538 |
Sensitive |
| ENSG00000180769.4 |
Motesanib |
Stomach adenocarcinoma |
0.00248867 |
Sensitive |
| ENSG00000182165.13 |
Motesanib |
Stomach adenocarcinoma |
0.027106126 |
Sensitive |
| ENSG00000203588.3 |
Motesanib |
Stomach adenocarcinoma |
0.028118202 |
Sensitive |
| ENSG00000214870.4 |
Motesanib |
Stomach adenocarcinoma |
0.002523786 |
Sensitive |
| ENSG00000222041.6 |
Motesanib |
Stomach adenocarcinoma |
0.023052507 |
Sensitive |
| ENSG00000223478.1 |
Motesanib |
Stomach adenocarcinoma |
0.008485444 |
Sensitive |
| ENSG00000224063.1 |
Motesanib |
Stomach adenocarcinoma |
0.001426619 |
Sensitive |
| ENSG00000224514.1 |
Motesanib |
Stomach adenocarcinoma |
0.021145526 |
Sensitive |
| ENSG00000224687.1 |
Motesanib |
Stomach adenocarcinoma |
0.029165082 |
Sensitive |
| ENSG00000224985.1 |
Motesanib |
Stomach adenocarcinoma |
0.018377571 |
Sensitive |
| ENSG00000225335.2 |
Motesanib |
Stomach adenocarcinoma |
0.029245088 |
Sensitive |
| ENSG00000225361.3 |
Motesanib |
Stomach adenocarcinoma |
0.013738649 |
Sensitive |
| ENSG00000225643.1 |
Motesanib |
Stomach adenocarcinoma |
0.047434073 |
Sensitive |
| ENSG00000225675.2 |
Motesanib |
Stomach adenocarcinoma |
0.024189241 |
Sensitive |
| ENSG00000226334.1 |
Motesanib |
Stomach adenocarcinoma |
0.018779053 |
Sensitive |
| ENSG00000227070.1 |
Motesanib |
Stomach adenocarcinoma |
0.028687676 |
Sensitive |
| ENSG00000227375.1 |
Motesanib |
Stomach adenocarcinoma |
0.025169603 |
Sensitive |
| ENSG00000227431.1 |
Motesanib |
Stomach adenocarcinoma |
0.040704242 |
Sensitive |
| ENSG00000227477.1 |
Motesanib |
Stomach adenocarcinoma |
0.021311143 |
Sensitive |
| ENSG00000227885.1 |
Motesanib |
Stomach adenocarcinoma |
0.047322247 |
Sensitive |
| ENSG00000228192.3 |
Motesanib |
Stomach adenocarcinoma |
0.02794383 |
Sensitive |
| ENSG00000228265.1 |
Motesanib |
Stomach adenocarcinoma |
0.031083156 |
Sensitive |
| ENSG00000228801.5 |
Motesanib |
Stomach adenocarcinoma |
0.034556039 |
Sensitive |
| ENSG00000228812.3 |
Motesanib |
Stomach adenocarcinoma |
0.035845255 |
Sensitive |
| ENSG00000229261.1 |
Motesanib |
Stomach adenocarcinoma |
0.007208193 |
Sensitive |
| ENSG00000230310.1 |
Motesanib |
Stomach adenocarcinoma |
0.005981035 |
Sensitive |
| ENSG00000230939.1 |
Motesanib |
Stomach adenocarcinoma |
0.004581563 |
Sensitive |
| ENSG00000231483.1 |
Motesanib |
Stomach adenocarcinoma |
0.003235358 |
Sensitive |
| ENSG00000232006.4 |
Motesanib |
Stomach adenocarcinoma |
0.01072322 |
Sensitive |
| ENSG00000232082.1 |
Motesanib |
Stomach adenocarcinoma |
0.033935039 |
Sensitive |
| ENSG00000232139.1 |
Motesanib |
Stomach adenocarcinoma |
0.022366835 |
Sensitive |
| ENSG00000233621.1 |
Motesanib |
Stomach adenocarcinoma |
0.034917771 |
Sensitive |
| ENSG00000233654.1 |
Motesanib |
Stomach adenocarcinoma |
0.026011756 |
Sensitive |
| ENSG00000233775.1 |
Motesanib |
Stomach adenocarcinoma |
0.030205783 |
Sensitive |
| ENSG00000233854.1 |
Motesanib |
Stomach adenocarcinoma |
0.000579431 |
Sensitive |
| ENSG00000233901.1 |
Motesanib |
Stomach adenocarcinoma |
0.038971404 |
Sensitive |
| ENSG00000234665.4 |
Motesanib |
Stomach adenocarcinoma |
0.03363354 |
Sensitive |
| ENSG00000234773.2 |
Motesanib |
Stomach adenocarcinoma |
0.016334627 |
Sensitive |
| ENSG00000234996.3 |
Motesanib |
Stomach adenocarcinoma |
0.025071303 |
Sensitive |
| ENSG00000235560.3 |
Motesanib |
Stomach adenocarcinoma |
0.001672808 |
Sensitive |
| ENSG00000235726.1 |
Motesanib |
Stomach adenocarcinoma |
0.035745394 |
Sensitive |
| ENSG00000236601.1 |
Motesanib |
Stomach adenocarcinoma |
0.004572333 |
Sensitive |
| ENSG00000236682.1 |
Motesanib |
Stomach adenocarcinoma |
0.010097586 |
Sensitive |
| ENSG00000236810.1 |
Motesanib |
Stomach adenocarcinoma |
0.025894906 |
Sensitive |
| ENSG00000236830.2 |
Motesanib |
Stomach adenocarcinoma |
0.012405727 |
Sensitive |
| ENSG00000237188.3 |
Motesanib |
Stomach adenocarcinoma |
0.028587083 |
Sensitive |
| ENSG00000237357.1 |
Motesanib |
Stomach adenocarcinoma |
0.023168184 |
Sensitive |
| ENSG00000237819.1 |
Motesanib |
Stomach adenocarcinoma |
0.047181996 |
Sensitive |
| ENSG00000238160.1 |
Motesanib |
Stomach adenocarcinoma |
0.0000866 |
Sensitive |
| ENSG00000238266.1 |
Motesanib |
Stomach adenocarcinoma |
0.000151327 |
Sensitive |
| ENSG00000240350.1 |
Motesanib |
Stomach adenocarcinoma |
0.036414323 |
Sensitive |
| ENSG00000247735.2 |
Motesanib |
Stomach adenocarcinoma |
0.044825599 |
Sensitive |
| ENSG00000248100.2 |
Motesanib |
Stomach adenocarcinoma |
0.0000783 |
Sensitive |
| ENSG00000248161.1 |
Motesanib |
Stomach adenocarcinoma |
0.041814448 |
Sensitive |
| ENSG00000250608.1 |
Motesanib |
Stomach adenocarcinoma |
0.013738585 |
Sensitive |
| ENSG00000251298.1 |
Motesanib |
Stomach adenocarcinoma |
0.036679899 |
Sensitive |
| ENSG00000251555.1 |
Motesanib |
Stomach adenocarcinoma |
0.025712507 |
Sensitive |
| ENSG00000253784.1 |
Motesanib |
Stomach adenocarcinoma |
0.009997745 |
Sensitive |
| ENSG00000254028.1 |
Motesanib |
Stomach adenocarcinoma |
0.029772144 |
Sensitive |
| ENSG00000254731.1 |
Motesanib |
Stomach adenocarcinoma |
0.030016581 |
Sensitive |
| ENSG00000257222.1 |
Motesanib |
Stomach adenocarcinoma |
0.016778222 |
Sensitive |
| ENSG00000257636.2 |
Motesanib |
Stomach adenocarcinoma |
0.000925736 |
Sensitive |
| ENSG00000258443.1 |
Motesanib |
Stomach adenocarcinoma |
0.02552941 |
Sensitive |
| ENSG00000258623.1 |
Motesanib |
Stomach adenocarcinoma |
0.000548991 |
Sensitive |
| ENSG00000258789.1 |
Motesanib |
Stomach adenocarcinoma |
0.006744013 |
Sensitive |
| ENSG00000259048.1 |
Motesanib |
Stomach adenocarcinoma |
0.003973186 |
Sensitive |
| ENSG00000259146.2 |
Motesanib |
Stomach adenocarcinoma |
0.014364715 |
Sensitive |
| ENSG00000259230.1 |
Motesanib |
Stomach adenocarcinoma |
0.041656998 |
Sensitive |
| ENSG00000259345.1 |
Motesanib |
Stomach adenocarcinoma |
0.038907529 |
Sensitive |
| ENSG00000259424.1 |
Motesanib |
Stomach adenocarcinoma |
0.031640175 |
Sensitive |
| ENSG00000259775.1 |
Motesanib |
Stomach adenocarcinoma |
0.039527868 |
Sensitive |
| ENSG00000260000.2 |
Motesanib |
Stomach adenocarcinoma |
0.021343247 |
Sensitive |
| ENSG00000260209.1 |
Motesanib |
Stomach adenocarcinoma |
0.02188276 |
Sensitive |
| ENSG00000260257.1 |
Motesanib |
Stomach adenocarcinoma |
0.0246134 |
Sensitive |
| ENSG00000260645.1 |
Motesanib |
Stomach adenocarcinoma |
0.038125324 |
Sensitive |
| ENSG00000261051.1 |
Motesanib |
Stomach adenocarcinoma |
0.039504625 |
Sensitive |
| ENSG00000261360.1 |
Motesanib |
Stomach adenocarcinoma |
0.04901961 |
Sensitive |
| ENSG00000261533.1 |
Motesanib |
Stomach adenocarcinoma |
0.024145086 |
Sensitive |
| ENSG00000261534.1 |
Motesanib |
Stomach adenocarcinoma |
0.048759357 |
Sensitive |
| ENSG00000262810.1 |
Motesanib |
Stomach adenocarcinoma |
0.044218576 |
Sensitive |
| ENSG00000266947.1 |
Motesanib |
Stomach adenocarcinoma |
0.012732711 |
Sensitive |
| ENSG00000267284.1 |
Motesanib |
Stomach adenocarcinoma |
0.001312557 |
Sensitive |
| ENSG00000267288.1 |
Motesanib |
Stomach adenocarcinoma |
0.003363954 |
Sensitive |
| ENSG00000267462.1 |
Motesanib |
Stomach adenocarcinoma |
0.001686717 |
Sensitive |
| ENSG00000267672.1 |
Motesanib |
Stomach adenocarcinoma |
0.023005128 |
Sensitive |
| ENSG00000267702.1 |
Motesanib |
Stomach adenocarcinoma |
0.008273605 |
Sensitive |
| ENSG00000267745.1 |
Motesanib |
Stomach adenocarcinoma |
0.010557373 |
Sensitive |
| ENSG00000268027.1 |
Motesanib |
Stomach adenocarcinoma |
0.027559482 |
Sensitive |
| ENSG00000269463.1 |
Motesanib |
Stomach adenocarcinoma |
0.022246506 |
Sensitive |
| ENSG00000269652.1 |
Motesanib |
Stomach adenocarcinoma |
0.045952507 |
Sensitive |
| ENSG00000269911.1 |
Motesanib |
Stomach adenocarcinoma |
0.006557596 |
Sensitive |
| ENSG00000269994.1 |
Motesanib |
Stomach adenocarcinoma |
0.000219162 |
Sensitive |
| ENSG00000270755.1 |
Motesanib |
Stomach adenocarcinoma |
0.046112283 |
Sensitive |
| ENSG00000270933.1 |
Motesanib |
Stomach adenocarcinoma |
0.000756561 |
Sensitive |
| ENSG00000271862.1 |
Motesanib |
Stomach adenocarcinoma |
0.045982356 |
Sensitive |
| ENSG00000271971.1 |
Motesanib |
Stomach adenocarcinoma |
0.042283153 |
Sensitive |
| ENSG00000272070.1 |
Motesanib |
Stomach adenocarcinoma |
0.045752873 |
Sensitive |
| ENSG00000272091.1 |
Motesanib |
Stomach adenocarcinoma |
0.046203142 |
Sensitive |
| ENSG00000272097.1 |
Motesanib |
Stomach adenocarcinoma |
0.042926449 |
Sensitive |
| ENSG00000272221.1 |
Motesanib |
Stomach adenocarcinoma |
0.031754223 |
Sensitive |
| ENSG00000272275.1 |
Motesanib |
Stomach adenocarcinoma |
0.01608186 |
Sensitive |
| ENSG00000272696.1 |
Motesanib |
Stomach adenocarcinoma |
0.036721963 |
Sensitive |
| ENSG00000272777.1 |
Motesanib |
Stomach adenocarcinoma |
0.033565817 |
Sensitive |
| ENSG00000272823.1 |
Motesanib |
Stomach adenocarcinoma |
0.04427253 |
Sensitive |
| ENSG00000272917.1 |
Motesanib |
Stomach adenocarcinoma |
0.038641882 |
Sensitive |
| ENSG00000273071.1 |
Motesanib |
Stomach adenocarcinoma |
0.041271029 |
Sensitive |
| ENSG00000273113.1 |
Motesanib |
Stomach adenocarcinoma |
0.046489692 |
Sensitive |
| ENSG00000273305.1 |
Motesanib |
Stomach adenocarcinoma |
0.030089134 |
Sensitive |
